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Abstract
Fiber-reinforced, Anisotropic Superporous Cryogels for Meniscal Replacement
Samuel James Laurencin
Giuseppe R. Palmese, Ph.D. and Anthony M. Lowman, Ph.D.
Menisci are anisotropic, semicircular fibrocartilaginous tissues that must withstand 
extensive loads and sustain adequate locomotion in the knee joints. Meniscal tears are the
most common intra-articular injury affecting the knee joint and consequently are the most 
common reason for procedures performed by orthopaedic surgeons. Once damaged, the 
partially vascular tissue has limited self-regenerative capabilities. Gold standard
treatment of meniscal tears involves controlled excision of the damaged area, which 
exposes more of the underlying cartilage to increased contact pressure and increase the 
risk of early onset osteoarthritis.
Currently, there is a critical need to develop a biomaterial that is firm enough to resist the 
high, anisotropic loads the menisci experience and can permit fixation to the rigid 
underlying bone, yet soft and lubricous enough to protect the cartilage it interfaces and 
allow for normal joint locomotion. Polyvinyl alcohol (PVA) cryogels are water swollen 
polymers (hydrogels) that undergo low temperature-induced physical crosslinking and 
have been proposed as a meniscal replacement due to their biocompatibility, low 
coefficient of friction and compressive strength, which can be tailored to match native 
menisci. The hydrogel’s mechanical capabilities are limited by its tensile strength being 
xiv
much lower than the meniscus. Fixation of a water swollen polymer into the joint space is 
also a challenge that must be addressed for the scaffold to restore normal joint mechanics. 
Through this research, it was demonstrated that ultra-high molecular weight polyethylene 
(UHMWPE) fibers could be introduced into a PVA cryogel in a controlled fashion using 
a coupon system. The interfacial shear strength between the fibers and cryogel were 
optimized using a 2-step process utilizing atmospheric pressure dielectric barrier 
discharge oxygen plasma and a glutaraldehyde covalent linkage. The presence of 
UHMWPE makes the cryogel anisotropic with respect to the direction of the applied
stress, consonant with the native menisci. A liquid-liquid phase separation technique was 
employed to create a second PVA phase with an interconnected superporous network to 
aid in vivo implant fixation through cellular infiltration along the scaffold periphery. The 
structural and functional properties of the superporous PVA can be dictated by the 
synthesis parameters and influenced by post-synthesis osmotic conditioning. Transport 
properties through the cryogel was also established. Finally, the two-phase, tri-
component cryogel was successfully scaled-up from the coupon system to native 
meniscus dimensions. This work provides great insight into the structural and functional 
features of fiber-reinforced, superporous cryogels and advances the field of biomaterials 
closer to a viable nondegradable meniscal replacement. 

1Chapter 1: Introduction
Meniscal tears are the most common intra-articular injury affecting the knee joint and 
consequently are the most common reason for procedures performed by orthopaedic 
surgeons [1]. Menisci are semicircular fibrocartilaginous tissue that must withstand 
extensive loads and sustain adequate locomotion in the knee joints [2-4]. They are able to 
convert compressive loads into transverse tensile loads [5, 6]. The hoop stresses that are 
formed are resisted by the tissue’s radially and circumferentially oriented collagen fibers. 
Once damaged, the partially vascular tissue has limited self-regenerative capabilities. 
When injury occurs, the shock absorbing and joint stabilizing functions of the meniscus 
are lost [7, 8]. Gold standard treatment of meniscal tears involves controlled excision of 
the damaged area, which exposes more of the underlying cartilage to increased contact 
pressure and increase the risk of early onset osteoarthritis [9, 10]. For large non-
repairable tears, meniscal allografts are a treatment option but donor availability and 
allograft sizing remains a challenge [11-13].
Researchers have proposed a myriad of novel materials, both degradable and 
nondegradable, to repair, regenerate or replace torn menisci [1, 14, 15]. Polyvinyl alcohol
(PVA) cryogels are water swollen polymers (hydrogels) that undergo low temperature-
induced physical crosslinking and have been proposed as a meniscal replacement due to 
their biocompatibility and compressive strength, which can be tailored to match native 
menisci [16, 17]. Incorporation of an secondary phase during the synthesis can influence 
the native porous structure and ultimately the function of the cryogel [18]. Biphasic 
2response to compressive loads, modulus within the range of native cartilage, low surface 
coefficient of friction, and low wear rates are all key factors of PVA cryogels that make 
them suitable for cartilaginous tissue repair [19]. The hydrogel’s mechanical capabilities 
are limited by its tensile strength being much lower than the meniscus [20]. Fixation of a 
water swollen polymer into the joint space is also a challenge that must be addressed for 
the scaffold to restore normal joint mechanics [12]. While natively biologically inert, 
tissue engineering techniques, utilizing extracellular matrix proteins [21] or encapsulated 
cells [22, 23], can further mimic native tissues and aid in successful in vivo integration. 
Preliminary work by Holloway et al. proposed the efficacy of a nondegradable, fiber-
reinforced cryogel composite scaffold using ultra high molecular weight polyethylene 
(UHMWPE) to replace damaged menisci [24]. However, despite the strong interest, 
tissue engineering-based treatment options for meniscal replacement have shown limited 
efficacy in the clinical setting [19, 25-27].
Currently, there is a critical need to develop a biomaterial that is firm enough to resist the 
high, anisotropic loads the menisci experience and can permit fixation to the rigid 
underlying bone, yet soft and lubricous enough to protect the cartilage it interfaces and 
allow for normal joint locomotion. Without addressing this need, the development of a 
hydrogel or similar biomaterial with properties suitable for meniscal replacement may 
remain unfulfilled. 
3Chapter 2: Background
2.1 Knee Joint Anatomy
Menisci are pairs of wedge-shaped cartilaginous tissues situated between the femoral 
condyles and tibial plateau. As seen in Figure 2.1, they are in close contact the stabilizing 
ligaments of the knee joint interact directly with articular cartilage above and below. 
They are also in close contact with the synovium making up the joint capsule. 
Figure 2.1: Knee joint gross anatomy [28].
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2.2.1 Composition
The meniscus has features of both fibrous tissue, with its extracellular matrix structure 
and composition, as well as cartilage tissue, with its territorial matrix around oval, 
cartilage-like cells and the presence of collagen type II [2]. Consequently, the meniscus is 
designated as fibrocartilage. The cells within the meniscus have properties found in both 
chondrocytes and fibroblasts, thus they are often classified as fibrochondrocytes. The 
meniscus is composed of 72% water, 22% collagen, and 0.8% proteoglycan. The collagen 
fibers form a complex interlacing hydroxylpyridinum aldehyde-crosslinked network 
encompassing the cells with the extracellular matrix of proteoglycans and glycoproteins. 
Over 90% of the collagen is type I collagen, having increased strength compared to the 
other types of collagen: II, III and VI.
2.2.2 Ultrastructure
An understanding of the menisci ultrastructure provides great insight into its functional 
properties. The primary orientation of collagen fibers is circumferential (Figure 2.2). 
Radially oriented fibers are also present, primarily within the inner two-thirds of the 
meniscus. The circumferential fibers serve to resist tension in the meniscus, while it is 
proposed that the radial fibers serve to hold the circumferential fibers together and also 
transfer axial compressive load from the femur to the tibia. There are randomly orientated 
collagen bundles at the surface of the meniscus similar to the collagen orientation in
articular cartilage. There is also zonal variation of proteoglycan content, with the inner 
5one one-third having approximately four times the concentration as the peripheral one-
third. 
Figure 2.2: Ultrastructure of meniscus [2].
While the cells within the meniscus can generally be classified as fibrochondrocytes, the 
predominance of the cell properties varies with location in the meniscus. The outer 
portion contains fibroblast-like cells and the inner and middle portions containing 
primarily fibrochondrocyte cells. The fibroblast-like cells lack the pericellular matrix 
found surrounding fibrochondrocytes but they do possess multiple cytoplasmic 
projections that contact neighboring cells, which has lead researchers to believe that the 
strong intercellular connections allow the outer portion of the meniscus to respond to 
mechanical loading and sense the tissue’s environment to maintain homeostasis [2].  The 
superficial zone contains cells with a distinct morphology that are believed to be 
progenitor cells, possibly arising from the synovium, and may play a role in meniscal 
wound repair.  
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6A perimeniscal capillary plexus exists around the periphery of the menisci. Radial fibers 
from this plexus penetrate the meniscus at intervals and generate a rich vascular outer 
one-third zone known as the red-red zone. The innermost one-third of the meniscus is 
avascular, thus referred to as the white-white zone, with a middle one-third transition area 
referred to as the red-white zone. Axons are found throughout the meniscus in a 
paravascular, likely supporting vasomotor action, and non-paravascular location. The 
additional presence of mechanoreceptors has suggested that the non-paravascular axons 
may support knee-joint afferent nerve transmission and joint proprioception. 
Vascularization of the medial meniscus is approximately 10-30% of the total width and is 
key factor of healthy tissue and impacts the self-repair capabilities of the meniscus.
2.2.3 Gross Anatomy
The menisci are pairs of fibrocartilage tissue found in both knee joints. They remain 
secured within the knee joint between the femoral condyles and the tibial plateau by 
fibers connecting the peripheral rim throughout its length to the joint capsule with the 
midpoint having firmer attachment via connection to the deep portion of the medial 
collateral ligament. There is also attachment to the inferior tibia by insertional ligaments 
connecting the circumferential fibers of the meniscus at the tapered ends anteriorly and 
posteriorly. These represent essential fixation points for the menisci although additional 
attachments with varying degrees of prevalence in the population and less defined clinical 
value exists, such as the anterior intermeniscal ligament connecting the menisci to each 
other at their anterior horns, the meniscofemoral ligaments connecting the menisci to the 
7femoral condyles superiorly, and the patella-tibial ligaments connecting the patella to the 
anterior horns of the menisci. The meniscal ligaments control the mobility and motion of 
the meniscus and thus sufficient meniscal attachment is essential for adequate 
functionality. 
2.3 Meniscus Biomechanics
The primary role of the meniscus is to transmit loads from the femur to the tibia. 
Supporting the role of various ligaments within the knee, the menisci also serve as 
secondary stabilizers and restraints to tibial internal-external rotation.  Their role as 
stabilizers is to resist tensile forces, which is accomplished by the collection of 
circumferential and radial tie-fibers that transmit compressive loads to radial and 
circumferential tensile loads. This allows the meniscus to redistribute contact force across 
the tibiofemoral area. The meniscus has been shown to have average tensile strength of 
110 MPa and 10 MPa in the circumferential and radial directions respectively. The elastic 
modulus ranges from 2 MPa to 23 MPa and is tissue location-dependent. The viscoelastic 
nature of the meniscus allows it to serve as a shock absorber of the knee. In 
menisectomized knees, the shock absorbing capacity is decreased by 20%. The 
compressive force placed on the meniscus is distributed over a portion of the articulating 
contact area. This creates a contact stress, which is proportional to the load and inversely 
proportional to the contacted surface area. The inner one-third experiences primarily 
compressive loads, which is supported by the higher concentration of 
glycosaminoglycans in this zone which serve to resist compression in a similar fashion to 
their role in articular cartilage. The high water content within a complex, interconnected 
8scaffold allows for water to act as an incompressible fluid under high rate loads where 
hydrostatic pressure resists the load and frictional drag created by the fluid attempting to 
escape is used to absorb the shock. Due to the impact of fluid flow, the instantaneous 
compressive strength has been shown to increase exponentially with level of strain, 
whereas higher strain rates limit the ability for fluid to escape and thus contribute to load 
resistance. The aggregate compressive modulus, representing an equilibrium state 
between fluid and solid tissue components, has been reported as 0.15 MPa with a 
corresponding permeability of 1.9 x 10-15 m4/Ns. 
Under load, the menisci have tendency to displace radially but this displacement is 
minimized primarily by the insertional ligaments, which creates hoop stress within the 
tissue. This allows the meniscus to deform by increasing its circumference to conform to 
the geometry of the femoral condyles during joint motion instead of being displaced and 
allows for distribution of the load. The menisci, however, do not perfectly distribute the 
load over the entire contact surface area. Under no load the contact within the knee is 
primarily over the meniscus but with large loads, such as 1470 N, the menisci cover only 
59 to 71% of joint contact surface area. MRI studies during knee flexion have shown that 
there is posterior excursion of the medial and lateral meniscus of 3.9 mm and 5.6 mm
respectively and peripheral movement of the medial and lateral meniscal bodies of 3.6
mm and 3.7 mm respectively during full extension to full flexion of a load-bearing knee. 
The lateral meniscus has greater mobility primarily due to less capsular attachment. The 
normal meniscal mobility is important criteria for developing replacements where 
fixation without implant movement hindrance is an important balance.
92.4 Meniscal Lesions
Meniscal lesions can be classified as traumatic, degenerative or a combination of both. 
Primary degenerative lesions typically occur in the fourth or fifth decade of life but can 
been seen earlier in certain demographics such as athletes. Despite the natural aging 
process of the meniscus, the possibilities of primary traumatic lesions or combined 
degenerative and traumatic lesions are possible in older individuals. The menisci can also 
be damaged as a result of injury to other structures within the knee. For example, damage 
to the anterior cruciate ligament causes increased stress on the meniscus as subsequent 
progressive meniscal destruction. 
Medial meniscus tears outnumber lateral meniscal tears by 2:1. This is likely due to the 
increased attachment sites and flatter surface of the tibial plateau over the medial 
meniscus causing the meniscus to bear more load with deep flexion while the lateral 
meniscus has greater posterior displacement under the same degree of flexion. The 
medial meniscus is often torn due to rotational forces experienced in a partially flexed 
knee. Circumferential splitting occurs more common than radial tears, possibly due to the 
higher load on the meniscus in circumferential orientation. However, radial tears disrupt 
the continuity of the circumferential fibers and are thus more detrimental to meniscal 
function.
2.4.1 Meniscal Damage and Osteoarthritis
The menisci combined occupy up to 71% of the intra-articular contact area within the 
knee joint, thus highlighting their importance as load bearing structures and their intimate
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relationship with articular cartilage. Englund et al. reports a complex relationship 
between meniscal damage and osteoarthritis in the knee [29]. A meniscal lesion in a 
healthy knee can lead to osteoarthritis and, conversely, osteoarthritis may lead to 
meniscal tears that further accelerate the osteoarthritis in the knee. Degenerative meniscal 
tears seen in middle-aged and elderly, as opposed to traumatic tears seen in the young, 
are often associated with preexisting structural articular cartilage changes, which may 
represent early stage osteoarthritis. The pathologic process causing early- stage 
osteoarthritis is also expected to affect meniscal and ligament integrity in a similar 
fashion. Shear stress and early proteolytic degradation of the meniscal matrix may result 
in decreased tensile strength. 
It is also common for middle-aged and elderly to experience meniscal extrusion, which is 
often a sign of meniscal degradation and existing osteoarthritis with moderate to large 
osteophytes or cartilage loss [2].  Meniscal extrusion may also contribute to increased 
joint-space narrowing seen on radiographs, which combined with meniscal tears and 
displacement are strong determinants of the rate of cartilage loss. Also, it is suggested 
that MRI-visible meniscal damage predates visible cartilage damage. There is a weak 
association between meniscal tears and knee symptoms in this age group, yet meniscal 
subluxation is highly associated with symptomatic knee osteoarthritis.
A study of 154 patients with osteoarthritis (mean age 53 years), found the prevalence of 
meniscal tears to be 76% in asymptomatic patients and 91% in symptomatic patients with 
osteoarthritis grade correlating with a higher frequency of meniscal tears [30]. Patients 
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with a degenerative meniscal tear on MRI had increased severity of cartilaginous lesions 
compared to the control group. This relationship was most prominent on the medial 
femorotibial side.
2.5 Treatments
2.5.1 Indication
The most common indication for surgery is repair of the main substance of the meniscus 
[2]. By comparison, tears of the periphery of the meniscus at the meniscosynovial 
junction are less frequent. Young age and recent injury are common indications to treat 
meniscal lesions. It is ideal to preserve the meniscus as much as possible when treating a 
meniscus tear. Of particular importance is the meniscal wall which serves to reduce the 
loading stress between femur and tibia by over 50%.
2.5.2 Repairable Meniscal Tears
Peripheral, longitudinal tears often have good functional results. This is due to the rich 
vascular network in this zone that utilizes a fibrin clot as a scaffold for vessel formation 
and mesenchymal stem cell proliferation with remodeling months later yielding meniscus 
tissue shape and mechanical properties. The avascular region has a less propensity for 
self-repair. Research has shown that meniscal cells do radially migrate to damaged 
avascular areas and attempt self-repair. This was shown by a canine meniscal injury plug 
model where a portion of tissue was taken from the avascular region, repeatedly frozen 
and thawed to destroy the contained cells and then re-implanted [31]. After one year the 
plug region was repopulated with cells, which demonstrates the meniscal cell migration 
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ability in response to injury despite overall poor haling and limited functional tissue 
restoration in the avascular zone.
More novel approaches are often an extension of traditional techniques. Mechanical 
trephination is a method to create vascular access channels to aid in healing meniscal 
lesions. The method involves abrasion or rasping of the adjacent synovium and the 
meniscal surface to stimulate bleeding and the release of growth factors to the healing 
area. Flaps are used, either free or pedicle type, to cover the meniscus or specifically over 
the tear. Wrapping the meniscus in a collagen matrix is a similar concept to using a free 
flap or fascia sheath coverage with the idea that the collagen will create a bioreactor 
environment guiding cell in-growth and improved suture stability. However this 
technique is technically demanding and time-consuming. 
Various options exist to aid repair of the avascular zone. These include connecting the 
inner portion to the outer via vascular access channels, creating a synovial flap to cover 
the lesion, or using a fibrin clot with or without growth factors at the lesion. While each 
option improves the healing capabilities of the avascular region, their results are limited 
by the formation of meniscal tissue that is incapable of normal meniscal function, as 
shown in canine studies where a fibrin clot filled a meniscal defect but the resulting tissue 
had higher aggregate modulus and lower permeability [32].
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2.5.3 Non-repairable Meniscal Tears
Menisectomy is often the first-line treatment for meniscal tears, with arthroscopic 
menisectomy considered the gold standard. However this often causes accelerated 
cartilage degradation and progressive osteoarthritis [2]. Following meniscectomy, 
patients are 14 times more likely to develop signs of osteoarthritis within 21 years on 
radiographs. Furthermore, medial meniscectomy has been shown to cause altered gait 
patterns. Therefore, meniscal substitution following a partial or total meniscectomy is a 
more favorable treatment option. Substitution is essential to prevent subsequent cartilage 
damage, restore biomechanical function and relieve pain. Multiple risk factors are 
correlated to a poor surgical prognosis when treating meniscal tears including: younger 
age at operation, presence of ligament injury, instability of the knee joint, presurgical 
presence of varus or valgus deformity and long preoperative duration of symptoms. 
Meniscal allografts are an option for non-repairable meniscal tears [33]. Allograft
transplantation provide pain relief and improved stability. They are indicated primarily 
for young patients with stable, minimally varus or valgus knee joints, and limited signs of 
osteoarthritis. Accurate meniscal allograft sizing is extremely important when performing 
meniscal transplantation using bony bridge fixation technique. Given the specific 
demographic indicated for allografts, they are not routinely performed. 
2.5 Tissue Engineering of the Meniscus
The field of tissue engineering has seen much growth in recent years with the ability to 
engineer a wide variety of synthetic and natural scaffolds [34]. Tissue engineering 
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approaches employ either natural or synthetic scaffolds and/or tissue-generating cell 
populations introduced to the defect site [35]. Numerous synthetic and natural scaffolds 
have been investigated to provide a 3-D environment for in vitro cell culture and 
introduction of cells to a defect site [36, 37]. Medical imaging and computer aided 
technology can be utilized to fabricate scaffolds with complex geometries and assess 
implant integration in situ [38, 39]. Scaffolds can support the culturing and 
transplantation of both mature chondrocytes and mesenchymal stem cells (MSCs) to treat 
defects. The use of MSCs is often preferred due to limitations in a donor source of 
autologous mature chondrocytes in some patients [38]. However, the use of stem cells 
requires increased control over the microenvironment during cell culture to regulate in 
vitro and in vivo differentiation [40].
There are basic requirements for scaffolds to be applicable for biomedical use including 
biocompatibility, structural stability, and adequate tissue integration [35]. For 
cartilaginous tissue applications, it is also important that the scaffold provide a low 
frictional index at the surface and restore mechanical integrity at the native site. The 
mechanical properties for a scaffold used in meniscal defect repair or replacement must 
exhibit the same ability to resist forces in compression, tension, and shear. Furthermore, 
the avascular nature of inner two-thirds of the meniscus requires consideration of the 
diffusive and transport properties within a scaffold to ensure proper nutrient delivery to 
the internal cells [41]. The diffusive and transport capabilities are a function of the 
scaffold’s porosity and permeability and water content. The porosity is a measure of the 
void volume of the material but other characteristics including pore size, pore geometry, 
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pore interconnectivity, and pore channel tortuosity must also be considered when 
describing the porosity of a scaffold. It is generally accepted that a high porosity, around 
90%, high interconnectivity, and high surface area-to-mass ratio is needed for uniform 
tissue ingrowth [41, 42]. However, this high porosity may compromise the integrity of 
certain materials for applications involving large physiological loads, thus optimization in 
porosity and mechanical properties must often be obtained. 
2.5.1 Novel Engineered Replacements
ActifitTM is a degradable aliphatic polycaprolactone-polyurethane-based scaffold 
developed to promote meniscal tissue ingrowth for treatment of partial meniscal tears. 
The MenaflexTM collagen meniscal implant was developed to serve as a porous 
biodegradable scaffold consisting of crosslinked type 1 collagen with glycosaminoglycan. 
It was reported to provide immediate restoration biomechanical function while allowing 
for cellular ingrowth and tissue regeneration during the scaffold degradative phase. 
MenaflexTM successfully completed clinical human trials and was FDA approved for 
marketing in the US. However, the FDA rescinded their approval in part due to concerns 
regarding the proven safety of the device. This demonstrates the importance of key 
understanding of the translational and clinical potential challenges in developing a tissue 
engineered meniscal replacement. Both implants require intact meniscal rim for tissue 
ingrowth [43]. NuSurface ® meniscal implant is a nondegradable polycarbonate-urethane 
and UHMWPE implant for total meniscal replacement. It replicates the discoid meniscus 
shape and thus does not require attachment in the knee joint. Clinical trials are currently 
ongoing in the US. 
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2.5.2 Hydrogels
Hydrogels are swellable polymer materials that can be degradable or nondegradable and 
have high concentrations of water, often up to 90% (w/w) [44]. Numerous research 
groups have been involved in extensive investigation in the use of hydrogels for various 
tissue engineering applications [45-48]. A common hydrogel used in biomedical 
applications is PVA [49]. The biocompatibility and mechanical properties of PVA has 
prompted investigation in its use to treat articular cartilage defects [50]. PVA has shown 
to display reduced wear behavior when chemically stabilized with PVP [51]. Blends of 
PVA-PVP have shown potential in the repair of various musculoskeletal tissues due to its 
nondegradable nature, mechanical strength, and low surface frictional index [52-55]. The 
synthesis method is an important consideration since the use of some polymer 
crosslinking agents and other synthesis materials can be harmful to cells. Freezing and 
thawing cycles can form physical crosslinks of adjacent polymer chains through 
hydrogen bonding, resulting in a 3-D cryogel with tunable material properties [49]. The 
designation of cryogel, as opposed to hydrogel, is reserved for freezing-temperature 
induced crosslinking.
2.5.3 Hydrogels for Meniscal Repair
Researchers have explored synthetic hydrogels for meniscal replacement applications. 
Kobayashi et al. investigated physically crosslinked PVA hydrogels [16]. The scaffold 
was compressive reinforced to permit suturing of the scaffold to the joint capsule in a 
rabbit model. After two years in vivo, the scaffold showed no breakage, shrinkage, 
dislocation or wear and demonstrated less cartilage wear than control groups. Following 
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that study, Kelly et al. investigated a fiber reinforced hydrogel in a large (ovine) animal 
model [56]. The fibers were used to secure the implant at the posterior and anterior horns. 
At 2 and 4 months the implant showed good chondroprotective ability. However, by one 
year follow up, the scaffolds failed due to propagation of a radial tear. Most recently, 
Holloway et al. further explored the potential for a fiber-reinforced PVA hydrogel as a 
meniscal replacement [24, 57]. This work focused in characterizing the functional 
capabilities of the hydrogel and improving the interface between the hydrogel and the 
fibers for better composite performance. These studies have demonstrated that PVA 
hydrogel with fiber-reinforcement has great potential as a meniscal replacement. 
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Chapter 3: Research Goals
The long-term goal of this project is to develop a nondegradable biomaterial that is 
clinically translatable and a viable treatment for non-repairable meniscal tears. The 
overall objective of this research, working towards the long-term goal, is to fabricate a 
cryogel that has material properties equivalent to menisci and also permits adequate 
nutrient transport and cellular proliferation and migration along the scaffold periphery for 
enhanced integration. To achieve this objective, the central hypothesis is that high-tensile 
strength fibers can be incorporated into a cryogel to make the, otherwise isotropic, 
cryogel mechanical properties anisotropic with respect to compressive and tensile 
strength, consonant with the native menisci. An interconnected porous network can be 
introduced into the cryogel through a novel liquid-liquid phase separation technique that 
has pore network features sufficient for cellular proliferation and migration in vivo to aid 
implant attachment and integration. The cryogel can be secured to the bone at natural 
fixation points through the embedded fibers and allow for contact pressures on 
interfacial cartilage remain at levels seen in the presence of fully functional native 
menisci. The rationale for the proposed research is that it will provide significant insight 
into (i) the relationship between scaffold synthesis, structure, and function and (ii) the 
cryogel’s potential as a biomaterial for meniscal replacement.
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To explore the validity of the central hypothesis, the following four specific aims are 
proposed:
Specific Aim 1: Synthesize and characterize cryogels reinforced with chemically grafted 
UHMWPE fibers. Hypothesis: Isotropic cryogels can be made anisotropic based on the 
rule-of-mixture where the tensile moduli of a composite fiber-cryogel will be 
significantly higher than that of a non-fiber reinforced cryogel due to the large tensile 
strength of UHMWPE. The compressive moduli will also increase due to the presence of 
fibers but to a much lesser degree. The effect of fibers on cryogel properties will be 
dependent on fiber volume, fiber spacing and orientation of fibers within the composite.
Specific Aim 2: Synthesize and characterize physically crosslinked, superporous cryogels. 
Hypothesis: PVA chemically stabilized with PVP can be synthesized using a novel 
liquid-liquid phase separation technique and form a scaffold containing an interconnected 
pore network that is dependent on the type of organic solvent used, solvent concentration, 
and mixing speed. The synthesis parameters will ultimately dictate the material properties 
such as compressive moduli and porosity. Swelling in conditions matching the knee joint 
will cause deswelling of the cryogel and changes in both structural and functional 
properties. 
Specific Aim 3: Characterize the transport properties of superporous and non-superporous 
cryogels. Hypothesis: The diffusion of proteins can be determined through permeation 
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chamber measurements. The rate of diffusion will be dependent on synthesis parameters 
and ultimately cryogel compositional and structural features. 
Specific Aim 4: Synthesize a meniscus dimension-matched fiber braid-reinforced cryogel 
with integrated superporous rim. Hypothesis: A complex fiber arrangement replicated the 
complex arrangement of collagen in native menisci can be introduced to the cryogel in a 
reproducible fashion. The cryogel with optimized material properties can be fashioned 
into the dimensions of the meniscus. A superporous cryogel periphery can be introduced 
to the bulk cryogel to form a stable tri-composite scaffold.
21
Chapter 4: Synthesize and characterize cryogels reinforced with chemically grafted 
UHMWPE fibers
4.1 Introduction
PVA cryogels have been proposed as a cartilaginous tissue replacement due to their 
biocompatibility and compressive strength, which can be tailored to match tissue-specific 
applications [16, 17]. Biphasic response to compressive loads, modulus within the range 
of native cartilage, low surface coefficient of friction, and low wear rates are all key 
factors of PVA cryogels that make them suitable for cartilaginous tissue repair [19, 57-
59]. For certain applications, the isotropic nature of cryogel’s mechanical strength would 
be advantageous. However, meniscus replacement requires anisotropic material 
functional properties. PVA-based hydrogels have a synthesis-structure-function 
relationship and can be tailored to have modulus values on par with menisci compressive 
and radial tensile moduli [60]. The hydrogel’s mechanical capabilities are limited by its 
tensile strength being much lower than the circumferential tensile modulus of the 
meniscus [20, 61, 62].
Holloway et al. proposed the use of a nondegradable, fiber-reinforced cryogel composite 
scaffold to replace damaged menisci [24]. The composite designed was proposed to take 
advantage of the beneficial features of the cryogel, while utilizing the high tensile 
strength of the embedded fibers. The study explored the use of both polypropylene and 
UHMWPE fiber mats that were added to PVA using a wet lay-up process leading to a 
multiple fiber mats contained within a cryogel without control over inter-fiber mat 
spacing or linearity of the mats. Tensile tests demonstrated a proportional relationship 
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between fiber volume and tensile modulus, with UHMWPE formulations reaching 258.1
MPa with 29% fiber volume. This value is well within the circumferential tensile 
modulus range of 100-300 MPa reported for native menisci [1]. Scanning electron 
micrograph of the cross-section of embedded fibers demonstrated PVA-rich regions 
defining holes surrounding the fibers with the hole size proportional to the fiber size. 
These holes were much larger than the fibers themselves and highlights the poor interface 
between the chemically inert fibers and PVA. To improve the interface, Holloway et al. 
developed a process to create reactive oxygen species on the fiber surface and covalently 
link to the PVA hydroxyl groups use glutaraldehyde as a linking agent [63]. The benefit 
of glutaraldehyde treatment was evident by the improved interfacial shear strength (IFSS) 
between the fiber and matrix. Despite the significant insight gained in the potential for 
covalently linked fiber-reinforced cryogels for meniscal replacement, more insight is 
needed into the impact of fiber type and fiber spacing within the matrix and the ability to 
incorporate fibers in a controlled and reproducible manner. 
This works explores the influence of UHMWPE braids on the tensile properties of PVA-
based cryogels.  The use of glutaraldehyde to improve interfacial properties of the 
composite with fibers of different diameters will also be assessed. Finally, the impact of 
fiber dispersion within the matrix on interfacial strength and resistance of tear 
propagation will be evaluated. An establishment of the tensile modulus, interfacial 
strength and tear strength will be essential in the development of a fiber-reinforced 
cryogel for meniscal replacement. 
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4.2 Materials and Methods
4.2.1 Materials
PVA (>99% hydrolyzed) with molecular weight 89,000 to 98,000 g mol-1 and polyvinyl 
pyrrolidone (PVP) with molecular weight of 58,000 g mol-1 were obtained from Sigma 
Aldrich (St. Louis, MO). Glutaraldehyde was also obtained from Sigma Aldrich. 
Dyneema® brand UHMWPE as braided fiber bundles (BFB) with 10 lb break strength 
was obtained from Lee Fisher International, Inc. (Tampa, Fl). The UHMWPE fibers were 
commercially available with intended use as a fishing line. They were received as a BFB 
and reduced to three single fiber braid (SFB) and further reduced to approximately 200 
single fibers (SF) using a custom designed mechanical separation process (Figure 4.1).
Due to the fragility of the SFs, they were tested as a collection of 200 separated SFs, or 
fiber tow (FT). 
24
Figure 4.1: Hierarchy of fibers used for composite synthesis
4.2.2 Scanning Electron Microscopy
Fiber diameter was determined from scanning electron micrographs. Fiber were coated 
with platinum and imaged in a high vacuum scanning electron microscopy (SEM) model
FEI/Phillips XL30 (Hillsboro, OR).
4.2.3 Cryogel Synthesis
PVA was made as a 10, 20, or 30 w% solution in deionized H2O. PVP was added to the 
PVA solution as a network stabilizing agent at a PVA to PVP ratio of 99:1 (w/w) [52].
The PVA-PVP solution was autoclaved at 121 oC for one hour with additional heating, if 
necessary, in a 90 oC oven until the polymer was completely dissolved. The solution was 
poured into 24-well polystyrene tissue culture trays to form cylindrical samples of 15 mm 
diameter and approximately 6 mm in height for compression testing or into dog-bone 
Braided Fiber Bundle
3 Fiber Braids
                    3 Separated Fiber Braids = 3 Fiber Tows
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shaped specimens using custom fabricated Teflon spacers secured between glass slides 
for tensile testing. The solution was subjected to six cycles of freezing at -21 oC for 21 
hours and thawing at room temperature for three hours to form a crosslinked cryogel.
4.2.4 Fiber-reinforced cryogel synthesis
A coupon system was designed and fabricated to control the spacing and orientation of 
fibers (Figure 4.2). The coupon system was used to scale-down from typical cryogel and 
fiber volumes needed for in vivo meniscal dimensions. BFBs or SFBs were thread 
through the coupon frame and spaced a minimum of 0.5 mm apart. Multiple rows were 
obtainable without control for spacing with respect to height within the cryogel. The 
fibers were held taught in the coupon system and encased between to dog-bone shaped 
Teflon spacers that were contained within two glass slides. PVA was added through an 
entry port with effort taken to prevent incorporation of air bubbles in the specimen. 
Tensile and tear testing samples were made into the dog-bone shape with a gauge length 
of 28 mm, width of 10 mm, and thickness of 2 mm. Fiber-reinforced samples for 
compression testing were made with 4 mm thickness and a single dog-bone shaped 
sample was cut into squares of 10 x10 mm. 
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Figure 4.2: Coupon system for controlled addition of fibers to PVA showing synthesis steps for tensile and compression specimen 
synthesis.
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4.2.5 Theoretical Composite Modulus Calculation
The upper bound of obtainable tensile modulus can be predicted by the rule-of-mixtures. 
This theoretical value is based on an external tensile load being applied in-line with the 
orientation of the parallel, continuous fibers within the matrix. The upper bound modulus, 
, can be calculated from the equation for the longitudinal tensile modulus:
where is the modulus of the fiber, is the volume fraction of fiber, and is the 
modulus of the matrix. Conversely, the low bound tensile modulus, , can be predicted 
by the equation for the transverse tensile modulus:
These equations provide a framework for what can be obtained in the fiber-reinforced 
system. The value of was determined from experimental tensile testing due 
to BFB modulus values not being available from the manufacturer. 
4.2.6 Chemical Grafting
Glutaraldehyde was used to create a covalent linkage between PVA and UHMWPE using 
previously described methods [63]. Briefly, a custom designed plasma reactor was used 
to produce reactive oxygen species on the fiber surface (Figure 4.3) [64]. Dielectric 
barrier discharge oxygen plasma using two charged plates at 1 W cm-2 under room 
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temperature and atmospheric pressure was employed. O2 was supplied at 1 L min-1 flow 
rate over the fiber surface for 6 minutes for optimal reactive group formation.[63]
Figure 4.3: Atmospheric pressure dielectric barrier discharge system with flow-
controlled oxygen delivery
Reactive UHMWPE fibers were submerged in 10 w% glutaraldehyde for 4 hours in the 
presence of an acid catalyst followed by suspension in 10 w% PVA with an acid catalyst 
overnight. The aldehyde-based crosslinking agent creates an acetyl bridge with 
subsequent covalent bonding. The glutaraldehyde-linked fibers are immersed in 10 w% 
PVA in the presence of an acid catalyst overnight to create a covalent link between the 
fiber surface and PVA polymer hydroxyl groups. The proposed reaction scheme is shown 
in Figure 4.4.
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Figure 4.4: Proposed reaction scheme for glutaraldehyde linkage between fiber surface 
and PVA hydroxyl groups [63].
4.2.7 X-ray Photoelectron Spectroscopy
The presence of reactive groups on fiber surface was confirmed with X-ray photoelectron 
spectroscopy (XPS) using a Physical Electronics PHI VersaProbe 5000 (Chanhassen, 
MN). An Al anode provided a scanning monochromatic x-ray source with a dual beam 
charge neutralization system used to prevent charging of samples. Survey spectra was 
acquired at 100 W from a pass energy of 117.4 eV, 0 to 1000 eV range, step size of 0.5 
eV and 20 ms dwell time. High resolution elemental C1 peaks were acquired at 100 W 
from a pass energy of 23.5 eV, 278 to 292 eV, step size of 0.2 eV and 50 ms dwell time. 
CasaXPS processing software was used for deconvolution of the high resolution C1s 
peak. Binding energy values for functional groups expected after oxygen plasma 
treatment are: 286.5 eV for hydroxyl (C-O) and 288.0 eV for carbonyl (C=O) and they 
were used to guide deconvolution peak fitting [64]. The area under each deconvoluted 
peak was used to calculate surface coverage of each functional group.
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4.2.8 Mechanical Testing
Mechanical performance and suitability as a cartilaginous tissue replacement was 
determined through unconfined compressive loading [65]. Compression testing was 
conducted using a bench-top Instron loading machine model 4442 (Norwood, MA) with a 
500 N load cell. Cylindrical cryogel specimens were subjected to a 0.1 N preload and 
compressed at 100 % min-1 to 50% strain. The compressive modulus was determined 
from the slope of the initial linear region of the stress-strain curve taken as 0 to 6% strain. 
Tensile testing was conducted using the same testing equipment and performed at 50 %
min-1 to failure with an initial 0.01 N preload. Tensile modulus was calculated as the 
initial linear region for non-reinforced specimens. For fiber-reinforced specimens, the 
initial strain range where the fibers were fully engaged as determined by the linearity of 
the curve’s slope was used to obtain the modulus. 
Pullout tests were conducted with a modified tensile testing set-up. Specimens were 
prepared as dog-bone shaped samples and half of the cryogel was cut away from the fiber 
after the first freeze-thaw cycle. This provided an embedded length of 30 mm. The 
exposed fiber was secured to the upper portion of the Instron stage through a metal 
attachment and the bottom embedded portion was held between sandpaper within the 
stationary tensile grips. The tests were conducted at a strain rate of 10 % min-1 to failure. 
The IFSS per fiber, , can be determined from the max force obtained during 
a fiber pullout test using the equation:
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where is the maximum force needed to separate the fiber from the cryogel, is the 
fiber diameter, is the embedded fiber length and is the number of fibers surrounded 
by the matrix. The shear strength of the cryogel represents the upper limit of the IFSS and 
was determined from previous studies to be 1.42 ± 0.20 MPa for 20 w% PVA [63].
Tear tests were conducted with a tensile test set-up. Specimens were subjected to a 5 mm 
notch and the max force required to propagate the notch was taken as the tear strength of 
the material. All tests were conducted with minimum replication of .
4.2.9 Statistical Analysis
One way analysis of variance (ANOVA) tests were conducted at a 95% confidence 
interval using GraphPad Prism software. Tukey’s multiple comparisons test at a 5% error 
rate was performed to compare multiple groups simultaneously when differences were 
found through ANOVA. In all figures, error bars represent ±1 SD and statistical 
significance is defined as p < .05. A significant change with respect to a previous 
concentration, volume or distance (independent variables) is denoted by #. A statistically 
significant difference between multiple formulations at a specific concentration, volume 
or distance (independent variables) is denoted by *. 
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4.3 Results
To evaluate the potential of a fiber-reinforced cryogel for meniscal replacement, the 
isotropic mechanical features of non-reinforced cryogels was first established. These 
results were contrasted to the composite mechanical properties using UHMWPE fiber-
reinforcement with and without the use of a covalent fiber-polymer linkage. For meniscal 
replacement applications, the tensile modulus and tear strength are of particular 
importance. 
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Figure 4.5: Representative stress versus strain behavior for a typical cryogel in 
compression (A) and in tension (B).
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Figure 4.5 shows the typical mechanical behavior of PVA cryogels in compression 
(Figure 4.5-a) and tension (Figure 4.5-b). PVA in compression exhibited a hyperplastic 
behavior. However, in tension, it was considered to behave linearly over the strain ranges 
of interest. Due to the irregularities at the surface of compression samples, a 0.1 N 
preload was applied, which is evident by the slight compressive stress at zero strain. The 
compressive modulus was taken as the slope of the best fit line through the 0 to 6% strain 
range. Tensile modulus was taken as the initial linear portion of the tensile stress-strain 
curve, in which the strain range varied based on the presence or absence of fiber 
reinforcement. 
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Figure 4.6: Cryogel modulus in tension and compression for 10, 20 and 30 w% PVA.
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Figure 4.6 highlights the functional properties of PVA cryogels. At each PVA 
concentration the cryogel exhibits similar modulus when tested in either compression or 
tension. The amount of PVA used in synthesis has a clear proportional relationship with 
modulus (p<.05). 30 w% was chosen as the limit for cryogel synthesis due to the high 
viscosity of 30 w% PVA, which can pose difficulty in the incorporation of UHMWPE 
fibers and thus affect sample reproducibility.
Figure 4.7: Scanning electron micrograph displaying fiber hierarchy for a braided fiber 
bundle (BFB), single fiber bundle (SB) and single fiber (SF).
Scanning electron microscopy (SEM) micrograph in Figure 4.7 shows the hierarchy of 
fibers used for composite synthesis:  braided fiber bundle (BFB), single fiber bundle 
(SFB) and single fiber (SF). Approximately 200 SFs are contained within a SFB with 
three SFBs braided to form a BFB. The average diameters for BFB, SFB and SF are 0.45 
mm, 0.30 mm and 0.02 mm respectively. Fibers were incorporated into cryogels in a 
0.40 mm
BFB SFB SF
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controlled fashion as: i) BFB, ii) SFB or iii) fiber tows (FT) representing a collection of 
approximately 200 separated SFs per FT. 
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Figure 4.8: Fiber volume versus compressive modulus.
While the main goal of introducing UHMWPE fibers is to increase the tensile modulus of 
PVA cryogels and match the circumferential tensile modulus of menisci, Figure 4.8
demonstrates that the presence of BFB also influences the compressive modulus. There is 
a slight increase in modulus over the control with increases in fiber volume. The increase 
in modulus from BFB in 10 w% PVA does not reach a level on par with the native 
menisci compressive modulus of approximately 0.16 MPa (at 6% strain) [5], it does 
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provide insight into the interaction between the cryogel matrix and UHMWPE fibers. In 
unconfined compression, the PVA is able to deform radially under the compressive load. 
The presence of the BFB appears to inhibit the complete deformation and allows the 
matrix to increase its resistance to the applied load.
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Figure 4.9: Stress versus strain behavior for a typical cryogel in tension with fiber 
reinforcement. Profile depicted is for 10 w% PVA with 0.12 v% BFB.
Figures 4.9 shows the typical stress-train profile of composite formulations. The 
maximum stress obtained can differ greatly within each formulation tested. The 
maximum stress obtained represents the point at which failure occurs within the fiber-
composite interface followed by a reduction in stress due to reduced impact of fibers 
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resisting the external force. For samples that maintained good contact within the Instron 
tensile grips, a second increase is seen which is due to resistance of external load by the 
matrix until failure of the cryogel is reached.
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Figure 4.10: Tensile stress-strain profile of 10 w% PVA cryogel and single BFB and a 10 
w% PVA single BFB-reinforced composite.
The typical stress-strain profile for: i) plain cryogel, ii) plain fiber bundle, and iii) cryogel 
reinforced with single BFB (0.04 v%) is seen in Figure 4.10. The difference in slopes for 
plain cryogel and plain fiber indicates the drastic difference in modulus of the two 
materials. The composite slope shows the influence of both components on the overall 
composite profile. The maximum stress on the composite is the point of interfacial failure 
followed by movement of the fiber within the matrix. There is a brief period of increased 
strain with constant stress for both the composite and plain BFB. This is due to 
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experimental error of the Instron system and reflects straightening and full engagement of 
the fibers followed by movement of the upper specimen clamp. It does not reflect a true 
behavior of the sample. 
The coupon system permits multiple BFBs to be added in parallel within one plane and 
equally spaced. It is important to determine how the spacing of the fibers may affect the 
stress-transfer ability of the composite and consequently the effect on modulus. 
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Figure 4.11: Tensile modulus with respect to interfiber distance for 0.43 v% BFB 10 w% 
PVA cryogel.
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The coupon system permits multiple BFBs or SFBs to be added in parallel and equally 
spaced within the horizontal plane. It is important to determine how the spacing of the 
fibers may affect the stress-transfer ability of the composite and consequently the effect 
on modulus. It can be seen from Figure 4.11 that there while there appears to be a trend 
toward decreasing tensile modulus with increasing BFB distance in 10 w% PVA, there is 
no statistical difference between the values (p>.05). The coupon system was limited to a 
minimum interfiber distance of 0.5 mm and maximum distance of 2.0 mm. Despite the 
lack of difference due to spacing within the limited range evaluated, subsequent 
formulations were synthesized with a fiber spacing of 0.5 mm unless otherwise noted to 
control for the potential effect of fiber spacing on composite properties. 
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Figure 4.12: Tensile moduli of various BFB volumes for 10 and 30 w% PVA.
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Figure 4.12 shows the tensile modulus with respect to fiber bundle volume for 10 and 30 
w% PVA.  The addition of 0.04 v% has a large impact over 0.00 v% (control) 
formulations at both PVA concentrations. For both 10 and 30 w% PVA there is a 
significant increase in tensile modulus for 0.04 to 0.43 v%, with further increases in 
modulus at 0.86 and 1.30 v%. 1.30 v% represents the upper limit of BFBs and SFBs that 
can be introduced into the cryogel in a reproducible fashion using the coupon system 
designed. The use of 30 w% PVA over 10 w% PVA produces a significant increase in 
modulus at each fiber bundle volume fraction except 1.30 v%. The maximum modulus at 
30 w% PVA with 1.30 v% BFB approaches 60 MPa. 
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Figure 4.13: Upper and lower bound tensile moduli based on rule of mixtures versus the
experimental tensile moduli at various BFB volumes.
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Figure 4.13 compares the predicted upper and lower bounds of the composite tensile 
modulus based on the rule-of-mixtures. While there is very good agreement with the 
upper bound and the experimental modulus at low BFB volumes, the upper bound is an 
order of magnitude higher with increased BFB volume. With force applied along the 
direction of fiber orientation, it is expected that the experimental values would closely 
match the upper bound. An understanding of the cause of the discrepancy between 
theoretical and experimental tensile modulus can be gained by evaluating the interfacial 
properties of the composite. Tensile modulus is a bulk material property and does not 
provide insight into the strength of the composite interface, which can be a potential 
source of failure in vivo if not adequate to resist external loads. Fiber pullout tests are 
used to assess the strength of the interface between the fiber and matrix. It is expected 
that the IFSS will be relatively poor since both PVA cryogel and UHMWPE are 
relatively inert. Thus atmospheric pressure dielectric barrier discharge oxygen plasma 
deposition followed by glutaraldehyde covalent linking was used to strengthen the 
composite interface. Confirmation that reactive oxygen species were created on the 
surface was made through XPS as shown in Figure 4.14.
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Figure 4.14: X-ray photoelectron spectroscopy spectra for both (A) untreated and (B)
treated fiber surfaces.
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Fiber 4.14-a shows the presence of C-C and C-H on the untreated fiber surface. After 
plasma oxygen treatment, as shown in Figure 4.14-b, the formation of C-O and C=O 
groups is evident, with an estimated surface area coverage of 33.18% and 7.15% 
respectively. Through chemical treatment of the UHMWPE surface, improvements in 
the fiber-matrix interface are expected. 
As shown in Figure 4.11, there is a trend toward inversely proportional relationship 
between inter-fiber distance and modulus although the affect is not apparent given the 
limited range of distances capable with the coupon system. In addition to evaluating the 
impact on glutaraldehyde treatment, pullout studies were conducted evaluating the impact 
of small fiber diameter, low interfiber distance on the IFSS using FTs. The coupon 
system was not equipped to incorporate FTs into the cryogel, thus less control was 
retained over the orientation and dispersion of FTs within the cryogels. Figure 4.15
provides optical images showing the cross-section of cryogels with BFBs and FTs. 
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Figure 4.15: Optical micrographs of cryogel cross-section with (A) dispersed 1 v% BFB in 10 w% PVA, (B) 1 v% FT in 10 w% PVA 
and (C) 1 v% FT in 30 w% PVA.
B CA
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Figures 4.15 shows the cross-section of reinforced cryogels. Incorporation of BFB and 
FT as shown in 4.15-a and 4.15-b respectively, highlights the minimization of interfiber 
matrix volume for FT reinforcements. Figure 4.15-c shows the effect of PVA w%, and 
thus polymer viscosity during cryogel synthesis, on the ability to incorporate FTs. The 
high viscosity of 30 w% PVA causes agglomeration of fiber tows compared to low 
viscosity 10 w% PVA that permits good dispersion of the fibers throughout the cryogel. 
The use of glutaraldehyde and the dispersion of fibers was evaluated in fiber pullout tests. 
A typical force versus extension curve for a pullout test using a 30 mm SFB or FT 
embedded length is shown in Figure 4.16.
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Figure 4.16: Representative force versus extension curve obtained from a fiber pullout 
test.
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Figure 4.16 shows that there is a linear relationship between force and extension during 
the pullout test. The maximum force represents the point at which the applied force 
exceeds the interactive forces between the SFB and matrix. The oscillating nature of the 
curve can be attributed to stretching and elastic recoil of the matrix during pulling of the 
exposed fiber. The impact of glutaraldehyde treatment, fiber dispersion and PVA w% on 
IFSS is summarized in Table 1.
Table 4.1: IFSS for SFB and FT reinforced cryogels with (+) and without (-)
glutaraldehyde treatment.
Table 1 displays the IFSS at 10 and 30 w% PVA for SFB and FT cryogels with and 
without glutaraldehyde surface treatment. Non-treated cryogels have a relatively poor 
fiber-cryogel interface as evident by the IFSS in Table 1. The use of glutaraldehyde 
drastically improves the IFSS at both 10 and 30 w% PVA (p<.05). Comparing FT to SFB 
formulations at 10 w% PVA, there does not appear to be a significant difference in IFSS 
(p>.05). However, when using the FT, the samples were more likely to fail within the 
fiber instead of consistently failing at the interface or within the matrix. It is not possible 
to differentiate between the interfacial failure and failure within the cryogel immediately 
PVA 
[w%]
Fiber 
Type
±
Glutaraldehyde [kPa/Fiber] SD Mode of Failure
10 SFB - 93.32 70.26 Interface/Matrix
10 SFB + 214.30 114.01 Interface/Matrix
10 FT - 89.98 28.09 Fiber; Interface/Matrix
10 FT + 194.15 30.39 Fiber; Interface/Matrix
30 SFB - 198.60 40.68 Interface/Matrix
30 SFB + 796.70 94.59 Interface/Matrix
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surrounding the fiber without high resolution imaging or surface analysis. This serves to 
under-report the true IFSS for FT formulations. Increasing the PVA w% had a significant 
impact on IFSS (p<.05), with the strongest interface contained within the SFB, 30 w% 
PVA +glutaraldehyde formulation. 
Meniscal damage typically involves the propagation of tears within the tissue, thus a 
potential biomaterial replacement must exhibit adequate tear strength in vitro. PVA alone 
cannot resist propagation of a tear under loads likely to be experienced in vivo. 
Composite tear tests were conducted for both SFBs and FTs at various fiber volumes. 
The tear strength of the material is taken as the peak force required to propagate the 
initial notch as shown in Figure 4.17.
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Figure 4.17: Representative force versus extension curve from a tear strength test.
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Figure 4.18: Peak load versus (a) SFB volume and (b) FT volume in 10 w% cryogel 
during tear strength testing.
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Figure 4.18-a shows the force required to tear the cryogel matrix when reinforced with 
fiber braids. The presence of braids interspersed amongst cryogel matrix causes a slight 
increase in peak load, thus increasing tear strength (p<.05). This is likely due to SFB 
entanglement resisting tear propagation.  Figure 4.18-b shows the force required to tear 
the cryogel matrix when reinforced with separated FT. The presence 0.04 v% of 
individual fibers of the FT interspersed amongst the cryogel matrix significantly 
improves cryogel tear strength over control strength (p<.05). Increasing the fiber volume 
to 1.00 v% leads to a drastic increase in force required to tear the cryogel (p<.05). Further 
increase of fiber volume to 1.30 v% does not significantly increase the tear strength 
beyond the 1.00 v% (p>.05). 
4.4 Discussion
In this study, the impact of fiber-reinforcement on the mechanical performance of 
isotropic PVA cryogels was established. The presence of 1.30 v% BFB produces a 
modulus increase from 0.05 MPa to 33.61 MPa for 10 w% PVA and 0.53 to 52.26 MPa 
for 30 w% PVA. This proportional relationship between fiber volume and modulus is 
advantageous from a meniscal replacement standpoint since an optimal fiber volume can 
be determined to produce modulus values equivalent to native tissue. For the meniscus, 
the circumferential and radial tensile moduli are on the order of 100-300 MPa and 10-100 
MPa respectively. Despite the large increase in modulus for a relatively small volume of 
fibers, the modulus approached 60 MPa, which is below the range of 100-300 MPa. 
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Increasing the fiber volume beyond the currently designed coupon system limitation of 
1.30 v% is expected to further increase the modulus. 
In addition to modifying the coupon system to permit incorporation of larger fiber 
volumes, the expected tensile modulus for fiber volumes tested can be predicted by the 
rule-of-mixtures. This theoretical value is based on volume of the composite components 
with an upper and lower bound value determined by the orientation of fibers with respect 
to the external tensile load. The maximum predicated modulus is found with the load 
being applied in-line with the orientation of the parallel, continuous fibers within the 
matrix. EUB predicts a 10 w% PVA tensile modulus of 6.88 MPa at 0.04 v% BFB and 
222.15 at 1.30 v% BFB. While, the low fiber volume predicted modulus is in close 
agreement with the experimental modulus, there is an order of magnitude difference at 
1.30 v% BFB. 
The difference between predicted and experimental moduli at high fiber volumes can be 
explained by the various assumptions used to develop the rule-of-mixtures. The theory 
assumes the composite has: i) perfect bond between matrix and fibers, ii) fibers are 
continuous and parallel and iii) the composite is free of voids, among other assumptions. 
Failure to satisfy all of these assumptions can cause disassociation between the 
experimental and predicted moduli. The coupon system was used to incorporate BFBs in 
a controlled fashion to maintain parallel alignment of the fibers. Repeated freezing and 
thawing of the cryogel causes slight deformation of the fiber alignment. In addition, fiber 
braids, such as the BFB used in tensile testing, contain void space between the SFs and 
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represents significant area where there is SF-SF interface and no stress transfer between 
fiber and matrix. Furthermore, repeated cryogel freezing and thawing expels water during 
the condensation of PVA polymer chains. The expelled water has been shown previously 
to condense around embedded the chemically inert UHMWPE fibers.  This also leads to 
failure to produce a perfect bond between matrix and fibers. All of these factors 
contribute to the inability to fully satisfy the assumptions of the rule-of-mixtures and 
explain why the experimental results are lower than the predicted values. 
The use of glutaraldehyde has been shown to be successful in improving the bond 
between fibers and the cryogel matrix, which helps satisfy the rule-of-mixtures. To 
eliminate the void space between SF within the BFB and SFB, the full separation of 
fibers to FTs was done, which serves to maximize the number of fibers interfacing with 
the PVA matrix. The impact of both steps was demonstrated by comparing the IFSS. As 
shown in Table 1, covalent linkage between UHMWPE and PVA improves the IFSS over 
non-glutaraldehyde treated formulations. The improved interface yields greater stress 
transfer between the composite components. Evaluating the influence of PVA w% shows 
that increasing PVA from 10 to 30 w% greatly increases the moduli. This is also a result 
of improved stress transfer, but in this case due to the increased density of matrix 
polymer chains. The increase in the number of embedded fibers surrounded by matrix 
through the use of FT instead of SFB did not have a significant impact on the IFSS. 
Contributing to the limited influence of increased fiber dispersion was the increased 
fragility of the exposed fibers during pullout testing. Specimens with greater separation 
of exposed fibers were more likely to fail within the fiber prior to reaching a force needed 
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for interfacial failure. This served to reduce the true IFSS for FT formulations and
represents a limitation of the research conducted.
Despite the lack of influence on IFSS, increased dispersion of SFs had a drastic impact on 
composite tear strength. The use of SFB or any composite designs where there is large 
areas of cryogel interspersed between the fibers poses a great risk for tear propagation 
through the matrix. The increase in tear strength using 0.04 v% SFB and maintained at 
1.00 v% is likely due to nonlinearity of the embedded fibers and slight fiber entanglement 
within the matrix. For a perfectly linear and parallel SFB arrangement with 0.5 mm 
interfiber spacing, the tear strength would be equivalent the tear strength of plain PVA, 
which is nearly the case with SFB formulations. The use of FT provides increased fiber 
dispersion within the matrix with significantly reduced mean interfiber matrix volume 
and greater fiber entanglement. This arrangement of fibers can drastically increase the 
tear strength over the cryogel tear strength when a sufficient concentration of fibers is 
used, in this case being between 0.04 and 1.00 v% FT. The correlation between fiber 
dispersion and tear strength has great implications for the design of fiber-reinforced 
composites for meniscal replacement since failure of native menisci is typically due to 
the propagation of tears. 
A significant limitation of the work presented is in the experimental set up of both tensile 
tests and fiber pull-out tests. There is currently no gold standard method to secure soft, 
hydrated biomaterials to tensile clamps. This is particularly challenging for fiber-
reinforced cryogels. For tensile modulus testing, sufficient grip must be maintained on 
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the embedded fibers to reflect to composite moduli. Conversely, for fiber pullout tests, 
gripping must be sufficient to secure the cryogel, but not prevent the movement of the 
embedded fibers. The use of large surface area tensile clamps with adjustable grip 
strength and sandpaper interfacing the cryogel and smooth clamp surface was shown to 
improve testing conditions. However, slipping of the samples during testing remained 
problematic and potentially led to lower modulus and pullout strength values that would 
be seen with better specimen gripping. 
4.5 Conclusion
This work explored the potential for a fiber-reinforced cryogel to serve as a 
nondegradable meniscal replacement and focused on the UHMWPE fibers’ ability to 
make a PVA cryogel anisotropic with respect to tensile modulus. Furthermore, the 
improvement of IFSS using a glutaraldehyde linkage was demonstrated. Finally, the 
benefit of highly dispersed fibers to resist tear propagation was demonstrated. 
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Chapter 5.0: Synthesize and characterize physically crosslinked, superporous  
cryogels
5.1 Introduction
For the replacement of tissues in the knee joint, such as articular cartilage or menisci, the 
mechanical performance must be suitable to withstand the high loads experienced. Of 
other great importance is the ability for a biomaterial to integrate with the surrounding 
tissue [19]. The native meniscus is secured in the joint space by multiple attachment sites 
including fibers connecting the peripheral rim to the joint capsule [2]. Previous hydrogel-
based meniscal replacement small and large animal model studies have indicated the 
importance to recreate these peripheral attachments to minimize implant migration during 
loading and excessive wear in tibial cartilage [16, 56]. While most biomaterials utilize 
suturing through the material to surrounding structures, hydrogels are limited by low 
pullout forces due to their hydrated nature. Even in the case of fiber reinforcement of 
hydrogels, the interaction between embedded fibers and suture can create local shear 
forces under joint loading and be a potential source of failure. In addition to direct 
attachment of the implant to the periphery during implantation, cellular ingrowth in vivo 
has been shown to aid implant integration and viability [66, 67]. The native meniscus is 
in close contact with the synovial membrane [2]. This membrane serves to provide 
nutrients to the cartilaginous tissue in addition to being a source of MSCs [68]. Meniscal 
replacements that support tissue ingrowth have demonstrated improved performance in 
vivo [67].
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While natively biologically inert, tissue engineering techniques, utilizing extracellular 
matrix proteins [21] or encapsulated cells [22, 23], can further mimic native tissues and 
aid in successful in vivo integration. This would be advantageous for tissue engineering 
approaches using autologous MSCs seeded on a conditioned cryogel in vivo to expedite 
cartilaginous tissue formation and integration in vivo [69]. Of utmost importance for 
cellular infiltration of the biomaterial in vitro and in vivo is the characteristics of the pore 
network [70, 71]. While physically crosslinked PVA-based cryogels have inherent 
porosity, the size of the pore network can limit the migration ability of seeded cells [57].
Cryogels have functional properties that can be tailored through the synthesis parameters 
employed, providing the developer significant controllability for a range of applications 
[72]. PVA cryogels can be synthesized through chemical or physical methods [44, 73].
Physical approaches are often preferred over chemical approaches for tissue engineering 
applications due to their lack of potentially cytotoxic crosslinking agents that can be 
difficult to remove post-synthesis. PVA-based cryogels can be synthesized through 
successive freeze-thaw cycling to form a nondegradable scaffold. Superporous cryogels 
for cartilaginous tissue applications were developed to enhance the degree of porosity and 
potential for native tissue integration and ultimately successful restoration of joint 
locomotion. Incorporation of an secondary phase during the synthesis can influence the 
porous structure and ultimately the function of the cryogel [18]. It is essential to 
demonstrate that a superporous cryogel does not sacrifice mechanical integrity for the 
sake of porosity and has compressive load-resisting properties on par with the 
cartilaginous tissue of interest [60].
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For fiber-reinforced composites, the presence of large pores would significantly reduce 
the stress-transfer capability of the composite. Consequently a superporous cryogel 
would not be advantageous as the bulk construct for a fiber-reinforced meniscal 
replacement. Due to the control provided over crosslinking rate by the freeze-thaw 
process, hydrogels with different properties through alternate synthesis methods can be 
combined to form two-phase cryogel composites. This would permit the combination of a 
superporous cryogel peripheral rim to a bulk, fiber-reinforced cryogel.
A liquid-liquid phase separation technique was explored by Spiller et al. for the treatment 
of articular cartilage focal defects [17]. This early investigation into superporous cryogels 
utilized a degradable poly (lactic-co-glycolic) (PLAGA) phase incorporated through a 
double emulsion process resulting in a PVA-PLGA composite solid matrix with PLGA 
microparticles contained in the pore network for potential drug or chemotactic delivery 
applications. Through confined compression testing, the aggregate modulus, permeability 
and time constant demonstrated cryogel behavior on par with cartilaginous tissue. The 
microspheres can release cell-stimulating growth factors in vivo to support cell migration 
and proliferation. Studies including a degradable phase within porous cryogels have 
shown a statistically significant impact on cryogel porosity but not always an effect on 
the functional properties of the cryogel to the same degree [74, 75].  The degradation of 
the microspheres can leave void areas within the cryogel matrix, thus their presence 
makes it difficult to directly study the synthesis-structure relationship of PVA 
superporous cryogels formed through the liquid-liquid phase separation technique and to 
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isolate the mechanisms by which the material changes in response to external stimuli 
such as osmotic pressure.  
An important feature of cryogels is their ability to swell or deswell in response to the 
osmotic pressure of their environment. This is critical for knee joint tissue applications, 
where the intra-articular osmotic pressure can drastically influence the in vitro 
equilibrium water content of cryogels. Traditionally, phosphate buffered saline (PBS) 
was used for in vitro swelling studies for cryogels for cartilaginous tissue applications, 
which does not impart the expected external pressures on the scaffolds that would be seen 
in vivo. Recent studies investigating the swelling behavior of cryogels have used more 
appropriate swelling mediums imparting knee joint osmotic pressure [58, 59].  For 
meniscal replacement, the change in implant volume that can occur in response to the 
osmotic pressure of the environment can lead to poor scaffold-native tissue interface and 
ultimately premature implant failure [59]. For a two-phase cryogel system, a large 
discrepancy in swelling properties may cause interfacial stress and be a potential source 
of implant failure. Furthermore, the internal pore network generated for in vivo cellular 
migration to promote implant incorporation may be negatively affect by swelling or 
deswelling behavior imparted by the osmotic pressure. The temporal factor of pore 
network change versus cellular migration rate would be important in this case. Thus a 
clear understating of the swelling behavior through in vitro swelling studies with 
appropriate osmotic pressures are needed to provide a context for the synthesis-structure-
function relationship of the scaffold and can also be useful in in vitro conditioning of 
cryogels prior to implantation.
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This work expands on previous studies that have demonstrated the use of liquid-liquid 
phase separation synthesis technique to generate an internal pore network via cyclic 
freezing-thawing cryogel formation [18]. The goal of the work presented is to explore the 
synthesis-structure-function relationship of fully nondegradable superporous cryogels 
through characterization of the pore network and the mechanical response to compressive 
loading. Various solvents- organic or lipid-based- were explored. By evaluating different 
synthesis parameters and organic solvent types, it is expected to provide insight into the 
controllability of the synthesis parameters for the development of a superporous cryogel 
suitable for use as part of a two-phase cryogel meniscal replacement. 
5.2 Materials and Methods
5.2.1 Materials
Phosphate buffered saline (PBS), dichloromethane (DCM) and ethyl acetate (EA) were 
purchased from Sigma Aldrich (St. Louis, MO).  Polyethylene glycol (PEG) of molecular 
weight 20,000 g mol-1 was purchased from Crescent Chemical Co (Islandia, NY). 
Dialysis tubing with molecular weight cut off of 3,500 g mol-1 was purchased from Fisher 
(Pittsburgh, PA).  
5.2.2. Superporous Cryogel Synthesis
Cryogels with a porous network were formed through a liquid-liquid phase separation 
technique modified from previously described methods [17]. Briefly, organic solvents-
DCM, EA, Oil, or ESBO- were added at various volume concentrations to PVA in 
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solution and mixed using an IKA RW 20 digital overhead mixer (Wilmington, NC) at 
300 or 1000 rpm for 10 minutes. The emulsion then followed the same cryogel synthesis 
procedure described in Aim 1. ESBO was mixed with and without the presence of an acid 
catalyst used to create a covalent linkage between ESBO and some PVA hydroxyl groups 
utilizing an epoxide ring-opening reaction.
5.2.3 Osmotic Conditioning
Menisci are subjected to an osmotic pressure of approximately 0.95 atm. To assess the 
influence of the in vivo environment on cryogels for cartilaginous tissue replacement 
applications, an in vitro swelling study was performed in a fashion similar to previous 
studies [59]. Briefly, PEG was dissolved in a PBS solution to generate a solution with 
osmotic pressure of 0.95 atm. The amount of PEG needed was approximately 92.3 g per 
/RI3%6DVGHWHUPLQHGIURPWKHIROORZLQJHTXDWLRQIRURVPRWLFSUHVVXUH
where is the universal gas constant, is the absolute temperature and is the 
polymer molecular weight. and are the second and third viral coefficients for 20,000 
g mol-1 PEG, which is 2.59 10-3 and 13.50 10-3 respectively [76]. Crosslinked 
cryogels were placed in a dialysis membrane and secured at both ends with clips to 
ensure no PEG adsorption onto the cryogel. The dialysis tubing containing cryogels was 
placed in the 0.95 atm PEG solution in a temperature-controlled water bath set to 37 oC. 
The volume of PEG solution was 100 times that of the total volume of submerged 
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cryogels to prevent alteration of the osmotic pressure from the flux of fluid into or out of 
the cryogels. Cryogels not subjected to osmotic conditioning served as controls for the 
effect of osmotic pressure on cryogels with respect to fluid content, compressive modulus 
and porous microstructure.  Cryogels were assessed between 1 and 28-day time points. 
5.2.4 Swelling Behavior
The fluid content of crosslinked cryogels before and after osmotic conditioning was 
determined through multiple weight measurements. At the pre-determined osmotic 
conditioning time points, cryogels were weighed then dried in an oven at 90 oC and re-
weighed to determine the fluid content, , as calculated from the following equation:
where is hydrated cryogel mass and is the dried cryogel mass. FC is an equivalent 
parameter to swelling ratio, which is commonly reported for hydrogels.
5.2.5 Mechanical Testing
Mechanical performance was determined through unconfined compressive loading in the 
same fashion as described in Aim 1 [65]. Cylindrical cryogel specimens ( ) were 
subjected to a 0.1 N preload and compressed at 100 % min-1 to 50% strain. The 
compressive modulus was determined from the slope of the initial linear region of the 
stress-strain curve taken as 10 to 16% strain for organic solvent formulations for better 
comparison with published data. 
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5.2.5 Microstructure
The average pore diameter of cryogels after osmotic conditioning was determined from 
environmental scanning electron microscopy (ESEM) use a FEI/Phillips XL30 
(Hillsboro, OR) or optical microscope images using a Zeiss Pascal 510 Confocal Imaging 
System (Oberkochen, Germany). Cross-sections for optical images were made through 
sectioning the bulk cryogel with a Vibratome Ultra Pro 5000 cryostat producing 20 Pm
sections.  Optical images were Environmental mode using ESEM, as opposed to 
traditional high vacuum mode, allows the cryogel to be imaged in its native hydrated 
state without the use of metal coating [17].
Images were taken at seven locations on the cross-section of the cryogel ( ) and the 
mean pore diameter (MPD) was determined using the US National Institutes of Health 
ImageJ software [77]. The same images were used to estimate overall cryogel porosity. 
The porosity was calculated from the ratio of the total porous area to the total surface area 
imaged. 
5.2.6 Statistical Analysis
One way analysis of variance (ANOVA) tests were conducted at a 95% confidence 
interval using GraphPad Prism software. Tukey’s multiple comparisons test at a 5% error 
rate was performed to compare multiple groups simultaneously when differences were 
found through ANOVA. In all figures, error bars represent ±1 SD and statistical 
significance is defined as p<.05. A significant change with respect to swelling time point 
or solvent volume from the previous value is denoted by #. A statistically significant 
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difference between multiple formulations at a specific swelling time point or solvent 
volume is denoted by *. 
5.3 Results
Through the liquid-liquid phase separation cryogel synthesis technique, a porous network 
is able to be formed throughout the cryogel that is dependent on the synthesis parameters. 
Of these parameters, the organic solvent concentration is of particular interest. For 
musculoskeletal replacement or repair applications it is of great importance to determine 
how the concentration of solvent used during the synthesis affects the crosslinked cryogel 
mechanical performance. Initial superporous cryogel studies utilized organic solvents-
DCM and EA- in the liquid-liquid phase separation to better compare with established 
literature. The formulations chosen for initial studies use a range of DCM or EA volume 
to establish the impact of solvent volume on structure and functional properties.
Table 5.1: Synthesis parameters for organic solvent formulations evaluated
Porogen Type Porogen v% PVA w% Mix Speed [rpm]
EA 10 10 1000
EA 25 10 1000
DCM 10 10 1000
DCM 25 10 1000
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Figure 5.1: FC versus swelling time for 0 (control), 10 and 25 v% DCM formulations.
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Figure 5.2: FC versus swelling time for 0 (control), 10 and 25 v% EA formulations.
As shown in Figures 5.1 and 5.2, the osmotic pressure results in a change in amount of 
liquid present in the cryogel. The liquid consists of water and any retained organic 
solvent not evaporated during synthesis. Cryogel controls synthesized without the 
presence of DCM as shown in Figure 5.1, exhibit a 25% loss of the liquid phase after 
seven days of osmotic conditioning. A further statistically significant reduction of the 
liquid phase is seen at 14 days, which then remains constant up to 21 days. After seven 
days of osmotic conditioning, the liquid content in DCM-synthesized cryogels exhibits 
the same trend as controls, with liquid phase content decreasing throughout the 14 days 
of swelling then remaining consistent from 14 to 21 days.  At the 7-day time point there 
is a greater loss of fluid from the DCM-synthesized cryogels compared to the control. 
67
There continues to be greater loss in fluid for 10 v% DCM cryogels at 14 and 21-day 
time points compared to controls but 25 v% DCM cryogels resulted in fluid content 
levels on par with controls at 14 and 21 days. The same effect of osmotic pressure on 
fluid loss with respect to swelling time of EA-synthesized cryogels is shown in Figure 
5.2, where both 10 and 25 v% EA cryogels exhibit a reduction in liquid content up to 14 
days. Unlike DCM cryogels, the only difference in fluid content when comparing the 
three formulations at each time point was seen between the control and 10 v% EA at 
seven days of swelling. 
The pore microstructure studies were conducted using EA due to poor controllability with 
DCM synthesized cryogels. It was observed that DCM cryogels had macroscopic void 
areas at the bottom of the crosslinked cryogels, which was not seen in EA synthesized 
cryogels. This is likely due to the higher density of DCM compared to EA causing 
settling of DCM prior to freezing temperatures being reached during the freeze-thaw 
process. While this settling behavior may not have impacted in vitro analysis of the 
cryogel, its potential for pore sample uniformity and reproducibility is a concern for 
future in vivo studies. Consequently, EA was selected for further testing. 
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Figure 5.3: ESEM micrographs displaying influence of swelling time on porosity. (A) 25 v% EA at 0-week swelling. (B) 25 v% EA at 
2-week swelling. (C) 25 v% EA at 4-week swelling.
50Pm
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Figure 5.4: ESEM micrographs displaying influence of solvent volume on porosity after osmotic conditioning. (A) 0 v% EA at 2-week 
swelling. (B) 10 v% EA at 2-week swelling. (C) 25 v% EA at 2-week swelling.
50Pm
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The % porosity is determined from the ESEM micrographs using ImageJ to calculate the 
void surface area versus the total imaged area. Figures 5.3 and 5.4 shows representative 
ESEM images highlighting the change in pore network due to swelling time and solvent 
volume, respectively. The mixing of DCM or EA within the PVA solution creates 
interspersed spherical organic solvent droplets. Freezing temperature-induced PVA chain 
crosslinking is prohibited where the organic solvent droplets are present. This liquid-
liquid phase separation yields a porous network that is highly dependent on the synthesis 
parameters. In figure 5.3, it is seen qualitatively that the pore size decreases over the 4-
week period while the overall porosity is relatively consistent. Focusing on the 2-week 
time point in Figure 5.4, the addition of EA increases both the overall porosity and pore 
size over the control samples. However, the solvent volume (10 and 25 v%) has a 
proportional influence on porosity but minimal impact on pore diameter. This qualitative 
trend observed through ESEM was consistent at each swelling time point. 
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Figure 5.5: Porosity versus swelling time for 10 EA and 25 v% EA formulations.
Figure 5.5 highlights the impact of solvent volume on the porosity over 28 days of 
swelling. At both EA concentrations the porosity remains consistent throughout the 
swelling study. A clear effect of solvent concentration is seen at each time point, where 
the larger EA concentration yields significantly larger void volume.
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Figure 5.6: MPD versus swelling time for 10 and 25 v% EA formulations.
After seven days of swelling, the MPD ranged from 10.4 to 25.7 Pm, with an average of 
15.0 Pm for 10 v% EA. At day seven, the higher EA content of 25 v%, yielded a 
statistically equivalent MPD to 10 v%, having a range of 10.0 to 18.3 and mean of 13.7 
Pm (Figure 5.6). Further significant decrease in MPD was seen at day 14, with 10 and 25 
v% EA displaying 8.2 and 9.6 Pm mean diameter respectively. From day 14 to day 28 
there is no significant change in MPD for either formulation. At each time point, there is 
overlap of the MPD range for both formulations, supporting the lack of statistical 
significance in the different diameters.
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Due to the large impact of swelling pressure on porosity of EA cryogels, alternative 
components for the liquid-liquid phase separation were explored. Oil and ESBO was 
evaluated as lipid-based porogens and were expected to have greater phase separation and 
improve the porosity. Furthermore, the presence of epoxides on ESBO are potentially 
capable reacting with free hydroxyl groups on PVA under the presence of an acid catalyst 
and increase the stability of the dispersed phase during freeze-thawing. Formulations 
were selected for swelling study based on preliminary porosity and compression testing 
results. Due to emulsion viscosity, phase separation and phase inversion not all PVA 
w%- Porogen v% combinations produced stable cryogels (Table 5.2).
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Table 5.2: Lipid-based porogens formulations attempted for cryogel synthesis.
Porogen Type Porogen v%
PVA 
w%
Mixing 
Speed 
[rpm]
Stable and 
Uniform 
Cryogel?
Adequate 
Porosity and 
Modulus?
Oil 10 10 300 Y Y
Oil 10 10 1000 Y Y
Oil 25 10 300 Y Y
Oil 25 10 1000 Y Y
Oil 10 20 300 Y N
Oil 10 20 1000 N -
Oil 25 20 300 Y N
Oil 25 20 1000 N -
Oil 10 30 300 N -
Oil 25 30 300 N -
Oil 25 30 1000 N -
ESBOc 10 10 300 Y Y
ESBOc 10 10 1000 Y Y
ESBOc 25 10 300 Y Y
ESBOc 25 10 1000 Y Y
ESBOr 10 10 300 Y Y
ESBOr 10 10 1000 Y Y
ESBOr 25 10 300 Y Y
ESBOr 25 10 1000 N -
ESBOr 10 20 300 Y Y
ESBOr 10 20 1000 N -
ESBOr 25 20 300 Y N
ESBOr 25 20 1000 N -
ESBOr 10 30 300 N -
ESBOr 25 30 300 N -
Porosity analysis and compressive moduli values were used to select from stable 
formulations for further testing. The benefit of lipid-based porogens was contrasted to 
control formulations that represent PVA mixed without added porogens with respect to 
porosity. Figure 5.7 demonstrates the effect of PVA w% and mixing speed on the cryogel 
pore network. 
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Figure 5.7: 0 v% porogen PVA cryogel porosity with respect to PVA w% and mixing 
speed.
The innate porosity of PVA cryogels is evident from the 0 rpm cryogel images. 
Increasing PVA w% leads to thicker polymer septum separate isolated pores and less 
dense polymer regions. Through mixing, air is entrapped within the polymer, with the 
degree of entrapment proportional to the viscosity of the polymer. This leads to small, 
highly distributed pores by low speed mixing and large pores from high speed mixing. 
The change in pore network when oil is used as a porogens is shown in Figure 5.8
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Figure 5.8:  Oil in 10 w% PVA porosity with respect to oil v% and mixing speed.
Figure 5.9:  Oil in 20 w% PVA porosity with respect to oil v% and mixing speed.
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Figure 5.8 and 5.9 shows the porosity obtained from oil porogens in 10 and 20 w% PVA 
respectively. Due to the low viscosity of 10 w% PVA both the continuous phase (PVA) 
and the dilute phase (oil) are well mixed resulting in a well distributed pore network. The 
effect of mixing speed is evident at both v%, where there is a decrease in average pore 
size with increased mixing speed. There is a decrease in the thickness of the polymer 
septum with increased v% and increased mixing speed. With 20 w% PVA large polymer 
septums are present, interspersed with islands of oil. In Figure 5.10, it is seen that there is 
a significant decrease in modulus at 10 v% when the mixing speed is increased. However 
this affect is not seen at 25 v% oil.
1 0 -0 1 0 -1 0 1 0 -2 5
0 .0 0
0 .0 2
0 .0 4
0 .0 6
0 .0 8
0 .1 0
P V A  w %  - P o ro g e n  v%
C
o
m
p
re
s
s
iv
e
 M
o
d
u
lu
s
 [
M
P
a
]
1 0 0 0 rp m
3 0 0 rp m
Figure 5.10: Compressive moduli of cryogels at various oil v% and mixing speeds.
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Figure 5.11:  ESBOc in 10 w% PVA porosity with respect to ESBOc v% and 
mixing speed.
Figure 5.11 shows the porosity obtained from ESBOc porogens in 10 w% PVA. Due to 
the low viscosity of 10 w% PVA both the continuous phase (PVA) and the dilute phase 
(oil) are well mixed resulting in a well distributed pore network. There is minimal effect 
of mixing speed evident at both v%, where there average pore size is similar at low and 
high mixing speeds. Increasing the ESBOc volume at a constant mixing speed leads to 
slightly larger pore diameter. Figure 5.12 shows that ESBOc produces statistically 
equivalent moduli for each formulation tested. 
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Figure 5.12: Compressive moduli of cryogels at various ESBOc v% and mixing speeds.
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Figure 5.13:  ESBO reacted in 10 w% PVA porosity with respect to v% and mixing 
speed.
Figure 5.14:  ESBOr in 20 w% PVA porosity with respect to ESBOr v% and mixing 
speed.
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Figure 5.13 and 5.14 shows the porosity obtained from ESBOr porogens in 10 and 20 
w% PVA respectively. Low v% and low mixing speed produces a highly variable pore 
diameter network with thick PVA septum. Increasing either the mixing speed or the 
ESBOr volume drastically decreases the average pore diameter and increases the pore 
uniformity while decreasing the thickness of the PVA septum. With 20 w% PVA two 
very distinct pore morphologies are formed. With low v%, a highly uniform, small 
diameter pore network is obtained. Increasing the volume leads to thick PVA septum
with islands of ESBOr. Figure 5.15 shows that increasing the solvent volume at 10 w% 
PVA significantly reduces the moduli, while no effect is seen from changing the mixing 
speed. At 20 w% PVA, the low v% ESBOr is on par with the control moduli, while high 
v% ESBOr has a significantly reduced moduli. 
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Figure 5.15: Compressive moduli of cryogels at various ESBOr v% and mixing speeds.
Of the stable cryogel formulations synthesized, those cryogels with porosity with 
adequate potential for cellular ingrowth were considered for further testing. Six 
formulations were selected for their potential for in vivo success and for the range in 
structural and functional properties they represent. The formulations selected are listed in 
Table 5.3 and the swelling ratio, compressive modulus and pore network was determined 
for each formulation over 14 days of swelling as shown in Figures 5.16 to 5.30.
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Table 5.3: Variation in solvent types, solvent volume, and PVA w% and mixing speed.
Porogen Type Porogen v% PVA w% Mix Speed [rpm]
Oil 25 10 300
Oil 25 10 1000
ESBOc 10 10 1000
ESBOr 10 10 300
ESBOr 10 10 1000
ESBOr 10 20 300
Figures 5.16 through 5.30 show the swelling ratio, compressive modulus and porosity at 
0 day and 14 day swelling for i) control formulations, ii) oil based formulation, iii) ESBO 
reacted and non-reacted formulations and iv) low and high concentration PVA 
formulations. 
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Figure 5.16: Control formulations swelling ratio versus swelling time. The legend 
indicates PVA w%-mixing speed
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Figure 5.17: Control formulations modulus versus swelling time. The legend indicates 
PVA w%-mixing speed. Porogen volume is indicated in the box.
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Figure 5.18: Control formulations pore structure versus swelling time. The rows are 
labeled as PVA w%-mixing speed rpm.
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Figures 5.16-5.18 includes the swelling ratio, compressive modulus and pore 
microstructure for control formulations. These controls were selected to match the actual 
PVA content cryogel formulations factoring in both initial polymer concentration and 
solvent concentration. 18 w% PVA performed best in regards to modulus and minimal 
deswelling. It was also the only formulation to have large, interspersed pores. However, 
these pores are also separated by thick PVA septum and do not appear to have significant 
interconnectivity. Lower PVA concentrations have a more fibrous topography with 
irregularly shaped pores. The pore network for each concentration remains fairly constant 
over 14 days of swelling despite the significant deswelling over the sample evident by the 
decrease in swelling ratio. 
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Figure 5.19: Oil at high and low mixing speed swelling ratio versus swelling time. The 
legend indicates porogen v%-mixing speed.
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Figure 5.20: Oil at high and low mixing speed modulus versus swelling time. The legend 
indicates porogen mixing speed. Porogen volume and PVA w% is indicated in the box.
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Figure 5.21: Oil at high and low mixing speed pore structure versus swelling time.
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Figures 5.19-5.21 show the swelling ratio, compressive modulus and pore network 
throughout 14 days of swelling. Oil–synthesized cryogels show a slight protective effect 
with respect to fluid loss. This effect is independent of mixing speed. Fluid loss remains 
consistent between seven and 14 days. Despite the fluid loss there is no significant 
change in modulus for either formulation over 14 days. The pore networks remain visibly 
consistent over 14 days.  
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Figure 5.22: ESBO reacted and unreacted swelling ratio versus swelling time. The 
legend indicates porogen v%-mixing speed.
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Figure 5.23: ESBO reacted and unreacted modulus versus swelling time. The legend 
indicates reaction conditions. Porogen v%-PVA w% and mixing speed is indicated in the 
box.
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Figure 5.24: ESBO reacted and unreacted pore network versus swelling time. The 
columns indicate porogen v%-mixing speed.
Figures 5.22-5.24 show the swelling ratio, compressive modulus and pore network 
throughout 14 days of swelling for ESBO with and without the presence of an acid. Both 
ESBOc and ESBOr show a slight protective effect with respect to fluid loss over the 
control by the 14 day time point. Fluid loss remains consistent between seven and 14 
days for both ESBOc and ESBOr. There is a small increase in modulus for ESBOc 
0 Day
14 Day
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between four and seven days swelling but not clear trend with respect to modulus for 
either formulation. There is greater definition of the pores for ESBOr after swelling, 
while ESBOc remains consistent with respect to pore network features. 
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Figure 5.25: Reacted ESBO at high and low mixing speed swelling ratio versus swelling 
time. The legend indicates ESBOr v%-mixing speed.
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Figure 5.26: Reacted ESBO at high and low mixing speed modulus versus swelling time. 
Legend ESBO mixing speed. ESBOr v%-PVA w% is indicated in the box.
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Figure 5.27: Reacted ESBO at high and low mixing speed swelling ratio versus swelling 
time. Columns represent ESBOr v%-mixing speed.
Figures 5.25-5.27 show the swelling ratio, compressive modulus and pore network 
throughout 14 days of swelling for ESBOr at high and low mixing speeds. Both high and 
low rpm formulations behave similarly with respect to fluid loss and both retain more 
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fluid than the controls. No trend is seen with respect to compressive modulus over 14 
days of swelling. Higher mixing speed produces smaller average pores with both 
formulations showing more defined PVA septum over 14 days of swelling.
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Figure 5.28: Low and high PVA concentration of reacted ESBO swelling ratio versus 
swelling time. Legend shows ESBOr PVA w%-mixing speed.
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Figure 5.29: Low and high PVA concentration of reacted ESBO swelling ratio versus 
swelling time. Legend ESBOr PVA w%. ESBOr v%-mixing speed is indicated in the box.
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Figure 5.30: Low and high PVA concentration of reacted ESBO pore structure versus 
swelling time. Columns represent ESBOr PVA w%-mixing speed.
Figures 5.28-5.30 show the swelling ratio, compressive modulus and pore network 
throughout 14 days of swelling for ESBOr at high and low PVA concentration. A clear 
distinction is made for the different formulations with respect to fluid loss. ESBOr with 
20 w% PVA retained the most fluid followed by the 18 w% PVA control. Both control 
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and non-control high PVA% demonstrated higher moduli than their respective lower 
PVA w% formulations. High w% PVA with ESBOr produces small uniform pores. Low 
w% PVA with ESBOr produces larger pores with greater variability. After swelling, there 
is greater definition of the pore network for both formulations. Both ESBOr formulations 
produce drastically different pore networks than their respective controls. 
5.4 Discussion
Due to the biologically inert nature of PVA cryogels, integration with surrounding tissue 
is a challenge that must be addressed. Previous work has incorporated degradable 
microspheres to serve as chemotactic agents for cellular ingrowth for the goal of 
improved integration following cellular proliferation [17, 74, 75]. Other researchers have 
focused on functionalization of the cryogel surface through chemical incorporation of 
biomimetic compounds [21] . While these added features have shown value in cartilage 
tissue engineering applications, the importance for stable, adequately sized internal pore 
network for cryogel based systems cannot be over-stated. Additionally, the pore 
microstructure has influence over the fluid behavior throughout the cryogel, which can 
indirectly influence the ability to resist external loads. 
The liquid-liquid phase separation method used in this research is advantageous due to: i) 
its simplicity from a polymer synthesis standpoint and ii) its controllability, showing a 
synthesis-structure-function relationship. DCM and EA were chosen as organic solvents 
due to their varied physical properties (i.e.: boiling point) and due to their potential for 
solvent extraction following cryogel crosslinking. Both DCM and EA are cytotoxic, thus 
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adequate extraction of the solvent is essential for in vivo applications. It is also expected 
that lipid-based porogens would negatively impact cell viability, thus adequate extraction 
of oil or ESBO would be needed for in vivo studies. A lipid extraction process utilizing 
repeated washes with ethanol followed by water was used prior to sample testing but no 
studies were done to quantify the amount of oil or ESBO remaining in the cryogel. The 
minimum amount of any porogen needed for optimized pore microstructure and modulus 
is important to determine, as amounts higher could unnecessarily complicate post-
synthesis solvent extraction.
Physically crosslinked PVA-based cryogels have inherent mechanical strength even at a 
relatively low polymer concentration of 10 w%. Repeated freeze-thawing causes 
condensation of PVA-rich domains and expels water into the formed pores  [58]. The 
larger volume of organic solvent is expected to produce greater solvent-rich, and 
conversely polymer-light, regions. Reducing the PVA-rich areas reduces the cryogel load 
baring capability due to the reduced solid matrix that primarily resists the external stress. 
There is a general trend of decreased modulus with increased porogen volume. This 
further supports the use of the minimum amount of porogen needed for optimal structural 
properties.
The fluid-filled pores are expected to act as incompressible fluids and contribute to the
compressive modulus, improving the mechanical capabilities over the inherent 
mechanical strength. The ability for the fluid phase to support resistance of compressive 
load is dependent on multiple factors, primary of which is the pore network features 
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including pore diameter and pore interconnectivity. Small pores that have a low 
interconnectivity or highly tortuous path are expected to exhibit reduced ability for 
solvent flow within the deforming matrix, thus increased ability to resist the external 
load. Conversely, large pores with high interconnectivity and low tortuosity should have 
less difficulty for solvent flow through the matrix and are thus less able to resist external 
loads. Both of these affects are strain-rate dependent, where high strain rates, during 
running for example, would not allow large polymer matrix deformation during loading, 
thus greater entrapment of fluid can be expected with greater load resistance capabilities. 
Traditionally, in vitro studies for biomaterials used PBS or similar solutions for material 
testing. PBS replicates body osmolarity and ion concentration but fails to fully recreate in 
vivo conditions. Charged macromolecules such as proteoglycans create an osmotic 
pressure in the knee joint, which has important implications for tissue replacement 
particularly when utilizing cryogels because their equilibrium fluid content and overall 
volume is influenced by external forces. The influence of osmotic pressure on the 
cryogels is reflected by a loss of fluid content. All formulations evaluated loss fluid over 
14 days of swelling. Interestingly, only PVA w% impacted fluid loss to a significant 
degree, where a greater initial polymer content led to less fluid loss. Since fluid loss is 
accompanied by a macroscopic decrease in cryogel volume, implantation of this PVA-
based cryogel into the knee joint prior to equilibrium could potentially cause a significant 
reduction of the cryogel volume. For bulk superporous cryogel applications, such as the 
case of cryogels for articular cartilage focal defect filling, the large volume reduction can 
lead to lessening of the cryogel and implant failure. For a two-phase cryogel system 
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where the superporous phase is solely occupies a small thickness of the periphery, the 
volume loss may be inconsequential. However, the actual thickness needed would may 
become significant if a larger superporous region is required to permit adequate cell 
migration and enhance implant stability. In vivo studies with superporous cryogel rims of 
variable thickness could be done to determine the minimal thickness needed. 
Alternatively, knowing the time point of in vitro cryogel equilibrium, shown to be 
between 7 and 14 days, allows for the cryogel to be conditioned in vitro and implanted at 
a time at which no further change in cryogel volume is expected.
The viscoelastic nature of the cryogel is due to the elastic strength of the polymer matrix 
in addition to the interaction between polymer and fluid phase during loading. It can be 
expected that the osmotic pressure decreases the overall fluid content in the cryogel and 
causes bulk condensation of the polymer phase, macroscopically seen as reduction in the 
cryogel volume, would also cause a change in the compressive modulus of the cryogel. 
However, osmotic conditioning did not consistently impart a significant change in 
modulus for the formulations tested. The consistent moduli can be explained by the 
ability for both organic solvents and lipids to act as external plasticizers when interacting 
with PVA chains and reduce the polymer stiffness [78]. This impact however does not 
Figures 5.30 and 5.27 display an increased definition of pore network during the swelling 
study. This may be explained by the difference in water phases present within the 
cryogel. Cryogels have two phases of water: bulk and bound [58]. The bulk water- with 
or without lipid- is present within the porous cryogel network and is more susceptible to 
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external forces driving its flow, such as osmotic pressure. Bound water has non-covalent 
interaction with the polymer side chains and is less susceptible to movement. The 
presence of epoxides in ESBOc and ESBOr may promote more movement of the bound 
water compared to oil formulations causing condensation of the regions and more defined 
pore network after deswelling. 
Since fluid loss alone does not appear to completely explain the lack of change in 
modulus during osmotic conditioning, it is important to evaluate how the pore 
microstructure is affected by osmotic pressure to explore its potential to influence fluid-
polymer matrix interaction under loading. Figures 5.3 and 5.4 provided qualitative insight 
into the pore features and ImageJ analysis of the cross-sectional images allow for 
quantification of the porosity and pore diameter with EA. There is a significant effect of 
organic solvent volume on the porosity of the cryogel with 25 v% EA having 
approximately 7.32% increase in porosity over 10 v% EA cryogels. This highlights how 
simply changing the organic solvent volume in the liquid-liquid phase separation 
approach can be used to control the cryogel porosity. However, optical images of lipid-
based formulations show a general constant pore network throughout the swelling study. 
The difference is likely due to the increased propensity for phase separation with lipid-
based formulations compared to EA. The change in MPD for EA is in line with the trend 
for fluid loss where no change is seen after 14 days of swelling. It is likely that 
condensation of the polymer matrix causes decrease in the MPD resulting in efflux of 
bulk water from the pores in response to the osmotic pressure. It is important to note that 
the changing pore diameter does not affect the overall porosity since the smaller MPD is 
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matched to increased number of pores within each imaged area, which is in line with the 
decrease in overall cryogel volume due to deswelling. The pore diameters remain 
generally consistent for lipid-based formulations, further highlighting the stability of the 
pore network using oil or ESBO.
There are various limitations to the work presented. The compressive modulus is an 
important biomaterial parameter to determine for meniscal replacement suitability but it 
does not fully explore the various mechanical forces the biomaterial would be subjected 
to in vivo. More robust mechanical testing is needed to determine how the cryogel may 
perform under these dynamic conditions. The importance of pore network features and its 
impact of fluid dynamics and functional performance was discussed. Of these features, 
the pore interconnectivity is expected to have significant impact on the fluid flow under 
loading and in response to osmotic pressure. Significant preliminary work was conducted 
exploring various techniques to quantify void volume and degree of interconnectivity, 
however the ability to determine these parameters of cryogels in their native, hydrated 
state remains a challenge. Of the pore network features studied- MPD and porosity-
ImageJ analysis of ESEM images remains one of the best, nondestructive methods to 
evaluate the pore network, despite the fact that imaging single, or even multiple two-
dimensional cross-sections only approximates the overall pore network structure. 
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5.0 Conclusion
Clear understanding of the synthesis-structure-function relationship of potential materials 
is vital to identify opportunities for optimization of the properties needed to promote 
restoration of joint function and successful implant integration for this potential two-
phase cryogel.  Through this work, the impact of PVA cryogel pore network and 
compressive moduli on synthesis parameters was established. Pore diameter larger than 
stem cell size is expected to be required for cell migration in vivo, which is evident in 
each of the lipid-based cryogels studied.  
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Chapter 6: Characterize the transport properties of superporous and non-
superporous cryogels
6.1 Introduction
Most research in biomaterials for meniscal replacement focuses on mechanical 
capabilities, biocompatibility, cellular ingrowth and chondroprotective ability. One area 
that has not received significant focus is the transport properties of meniscal 
replacements. Menisci are unique compared to other cartilaginous tissues, such as 
articular cartilage, due to their partial vascularity. This feature allows to the direct 
delivery of cell sustaining nutrients to the tissue [2]. From the periphery, these nutrients 
rely on diffusion to the remaining avascular regions of the meniscus. In addition, the 
meniscus further provides the delivery of nutrients to the avascular articular cartilage in 
the knee joint. While not the sole source of nutrients to chondrocytes, the meniscus does 
provide a pivotal role in regards to nutrient transport within the knee joint. Poor 
nutritional supply and inadequate removal of waste are believed to contribute to 
cartilaginous tissue degradation [79]. The diffusion coefficient through articular cartilage 
has been established for many solutes including glucose (D=1.4-2.3 x 10-10 m2/s) and 
serum albumin (D=0.2 x 10-10 m2/s) [80].
Much research has been devoted to transport properties of cryogels [81]. Cryogels 
themselves are often investigated for use as drug delivery devices, with many 
commercially available options present on the market [44, 82]. Transport through 
cryogels are a function of various controllable synthesis parameters including molecular 
weight between crosslinks, polymer weight fraction and pore size [83, 84]. Hydrogels can 
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be modified to further influence transport properties for a specific application. Similarly, 
cartilaginous tissue composition have influence over transport properties [80]. The water 
content of the tissue has significant influence over the transport [85].
For meniscal replacement applications the diffusion capabilities of the potential cryogel 
should be established. Since there is a clear synthesis-structure-function relationship for 
cryogels as established in Aim 2, an understanding of the diffusion requirements in the 
knee joint would guide the synthesis parameters for the cryogel. The superporous 
cryogels determined from Aim 2 to be suitable for use as a peripheral rim in meniscal 
replacement was evaluated for differences in protein transport. This is contrasted to the 
transport of a potential bulk phase cryogel formulation for meniscal replacement, in this 
case 18 w% PVA. An understanding of the transport capabilities through different 
hydrogel formulations can impact selection of synthesis parameters. 
6.2 Materials and Methods
6.2.1 Materials
PVA, PVP, PBS, oil, and ESBO was obtained from previously described sources. Bovine 
serum albumin was obtained from Sigma Aldrich. Pierce BSA Protein Assay Kit was 
purchased from Thermo Scientific. 
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6.2.2 Cryogel Synthesis
Cryogels formulations were synthesized through previously described methods. The 
formulations selected for transport studies is summarized in Table 6.1. They represent a 
range of water content and pore network features.
Table 6.1: Cryogel formulations selected for transport studies.
Porogen Type Porogen v% PVA w% 
Mixing Speed 
[rpm] 
Osmotically 
Conditioned? 
None 0 18 0 N 
None 0 18 300 N 
ESBOr 10 10 300 N 
ESBOr 10 20 300 N 
ESBOr 10 20 300 Y 
6.2.3 Diffusion Apparatus
A customs designed, six chamber diffusion apparatus was used to control transport 
through the cryogels (Figure 6.1). Cryogels were cut to 1 mm thickness by hand using a 
razor blade. Each glass chamber consisted of a separate upper and lower well. The 
cryogel was secured between the two chambers in slight compression using an external 
adjustable manual control. Each well had an opening of 9.33 mm diameter that interfaced 
both sides of the cryogel. The inner section of each well held 3 ml of fluid and the outer 
well permitted the flow of deionized H20 at a temperature of 32 oC to equilibrate with the 
inner section contents and represent knee joint intra-articular temperature. The flow 
through the outer section was maintained through the use of a temperature controlled 
water bath. 
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Figure 6.1: Custom six-chamber diffusion system.
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The upstream (with respect to outer chamber fluid flow direction) well contained 4
mg/ml bovine serum albumin (BSA) that was used as a representative protein for 
diffusivity calculations. The downstream well contained PBS. 25 Pl samples were taken 
from the downstream well at various time points until steady state was reached. 
6.2.4 Ultraviolet-visible Spectroscopy
A Tecan (Morrisville, NC) Infinite Pro 200 ultraviolet-visible spectrometer was used for 
BSA protein concentration determination. Diffusion samples and standards were 
subjected to steps outlined in the BSA protein assay kit. The samples were reacted with 
the assay kit reagents for 30 min at 37 oC then allowed to cool to room temperature. The 
solutions were measured for absorbance at 562 nm. The standard BSA solutions were 
used to create a protein concentration standards curve by fitting a fourth order 
polynomial, through which unknown concentrations could be interpolated. 
6.2.5 Diffusion Calculation
Diffusion calculations are modified from previous studies with similar experimental set-
up [82, 86, 87]. The diffusion system is represented by the schematic in Figure 6.2 with 
the associated boundary conditions. C1, C2, and Cc represent the protein concentrations in 
the upstream well, downstream well, and cryogel respectively. The diffusion is 
considered to be one-dimensional in the z direction through a cryogel of thickness h1.
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Figure 6.2: Diffusion study (A) schematic and (B) boundary conditions.
Boundary Conditions:
1) t=t0: Cc=C10 at z=0 and Cc  DW]K1
2) t>t0: Cc=C1 at z=0 and Cc=C2 at z=h1
3) C=C1 at z<0 and C=C2 at z>h1
4) N=C10V1 at t=t0 where N is the number of moles of solute in the system
Assumptions:
1) Well mixed solution in both wells
2) No concentration gradient in either well
3) Total sample loss of 5% is negligible
4) t Cc to stabilize to linear profile << t diffusion  (quasi-steady state)
To assume the solutions remain well mixed during the course of the experiment, the 
settling velocity can be used to establish the length of time before the effect of gravity on 
the BSA would be important. The settling velocity is based on Stokes Law:
A B
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where Us and Uf are the densities of the solute and fluid respectively, rs is the solute 
radius, and Pf is the fluid viscosity. This leads to a Xs value on the order of 10-3 cm/h. For 
a 1 cm high chamber this indicates a settling time over 900 h, which is less than the 72 h 
over which the diffusion was measured.
A one-dimensional steady-state diffusion is based on Fick’s Law:
where J is the flux and D1 is the diffusion coefficient. Since diffusion is only in the z
direction and independent of concentration, flux can be written as:
The concentration in the downstream well can be written as:
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where N is the number of moles of solute in the system, V is expressed as:
and W is expressed as:
C2 can be changed to the form:
where the slope of the curve in the form Y = mX can be used to calculate D1.
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6.3 Results
6.3.1 Standards curve
Through the use of the BSA protein assay kit the following standards curve was obtained. 
The fourth order polynomial has good fit to the data with r2 = 0.9999.
0 1 0 0 0 2 0 0 0 3 0 0 0 4 0 0 0 5 0 0 0
0
1
2
3
4
B S A  C o n ce n tra t io n  [Pg /m l]
A
b
s
o
rb
a
n
c
e
 [
n
m
]
y  =  - 2 E -1 5 x 4  +  4 E -1 1 x 3  -  3 E -0 7 x 2  +  0 .0 0 1 4 x  +  0 .0 0 4
R ²  =  0 .9 9 9 9
Figure 6.3: BSA standards curve.
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6.3.2 Diffusion Coefficient
Table 6.2 shows the diffusion coefficient for various cryogel formulations. 
Table 6.2: Diffusion coefficient values.
Porogen 
Type
Porogen 
v%
PVA 
w%
Mixing Speed 
[rpm]
Osmotically 
Conditioned?
D1 
[cm^2/s]
None 0 18 0 N 4.00E-09
None 0 18 300 N 3.00E-09
ESBOr 10 10 300 N 3.00E-08
ESBOr 10 20 300 N 1.00E-09
ESBOr 10 20 300 Y 1.00E-09
The diffusion coefficient for each formulation evaluated is shown in Table 6.2. Both 
control formulations have similar D1 values. A large increase in D1 is seen in the ESBOr 
10 v%-10 w%-300 rpm formulation. Both ESBOr with 20 w% with and without osmotic 
condition to equilibrium fluid content have equivalent D1 values. 
6.4 Discussion
Diffusion of molecules through native menisci is essential to support cell viability of 
surrounding articular cartilage. In addition, the bulk of the meniscus relies on diffusion of 
nutrients. Limited research has been done to evaluate the diffusive capabilities of 
biomaterials for meniscal replacement. For cryogel-based meniscal replacements, the 
synthesis parameters can have significant impact on the diffusive capabilities. This aim 
117
explored the impact of cryogel compositional and structural features on the diffusion 
coefficient using BSA as a model protein.
The control formulations tested have equivalent water content but different pore network 
features. The large isolated pores in 18 w% PVA- 300 rpm mixed formulation does not 
significantly impact the diffusion coefficient. This would support previous research that 
has demonstrated the close relationship between water content and diffusion coefficient. 
ESBOr with 20 w% PVA has a similar fluid content to both control formulations but a 
drastically different pore network. The smaller pores seen with ESBOr decrease D1
slightly but the values are still within the same order of magnitude. ESBOr with 10 w% 
has very large, well dispersed and likely highly interconnected pores. In addition, it also
has a larger fluid content than all other formulations tested. It is likely that the fluid 
content led to the large increase in D1. Cryogels under osmotic conditions found in the 
knee joint lose significant fluid as demonstrated by Aim 2. A conditioned ESBOr cryogel 
however, has equivalent D1 to a non-osmotically conditioned cryogel. This is likely due 
to the fact that 20 w% PVA formulations were shown to have mild fluid loss during a 
swelling study compared to lower w% PVA formulations. It is possible that the loss of 
fluid that would normally drive D1 down is matched by the highly porous nature (which 
remains consistent during deswelling) of these formulations resulting in equivalent 
diffusive capabilities. While the main purpose of this study was to explore the correlation 
between cryogel features and diffusivity, it is interesting to note that the diffusion 
coefficient of BSA through articular cartilage is 200 x 10-9 cm2/s, which highlights the 
great ability of cartilaginous tissues to permit diffusion of nutrients to the cells within.
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One limitation of the data presented is that the cryogels likely were not in a relaxed state 
throughout the experiment. Furthermore, is likely they were each under varied level of 
stress. The diffusion chamber requires manual tightening of the two wells to secure the 
sample in place. Cryogels under pressure can readily deform and extrude from their 
position, thus a significant amount of pressure was required to keep them in place. Care 
was taken to apply the same amount of external pressure on each chamber but it is likely 
there would be some variability in the actual amount each formulation experienced. Joint 
loading has significant impact on meniscal transport properties and evaluation of 
transport through cryogels under various loading conditions would be valuable to study. 
However the impact of joint loading on transport is outside the scope of this Aim.
6.5 Conclusions
This Aim demonstrated highlighted the importance of determining diffusive capabilities 
of synthetic meniscal replacements. The results suggest that fluid content, as opposed to 
porosity, have a significant influence on the diffusion coefficient.  This can aid in the 
selection of synthesis parameters for cryogel-based cartilaginous tissue replacement if 
future research suggests that a certain range for diffusion coefficient is needed for 
optimal implant performance. 
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Chapter 7: Synthesize a meniscus dimension-matched fiber-reinforced cryogel with
integrated superporous rim
7.1 Introduction
Tissue engineering of a native tissue requires extensive research into the components, 
synthesis parameters, structural features and functional capabilities of the engineered 
construct. This process typically entails first a strong comprehension of the theoretical 
and engineering principles of relevance for the material and for its application. A typical 
process entails material design, then synthesis, followed by relevant testing in vitro at 
various levels of scale. A recent paradigm shift has led researchers to understand the 
importance of translational research. Historically, the translational aspect of a biomaterial 
or similar construct was considered after repeated cycles of design, synthesis, and testing. 
It is widely recognized now that the successful development of a material for clinical 
applications is benefited from consideration of the translational challenges early in the 
developmental process [88].
The overall goal for this research project is to provide a foundation of knowledge to lead 
to the development of a clinically translatable meniscal replacement. The purpose of this 
aim is to provide a proof of concept that a superporous rim of optimal porosity and 
strength can be incorporated into the periphery of a mechanical-performance optimized, 
fiber-reinforced cryogel with the dimensions of a native meniscus. An understanding of 
the scale-up challenges may lead to novel design and engineering questions that may 
otherwise have been overlooked at this stage of the scientific investigation.
120
7.2 Materials and Methods
7.2.1 Materials
Optimized fiber-reinforced cryogels based on results from Aim 1 and optimized 
superporous cryogels based on results from Aims 2 and 3 will be selected for use in the 
development of a meniscal construct. Meniscal molds with bovine medical meniscus 
dimensions manufactured by the Hospital for Special Surgery will be used (Figure 7.1). 
Figure 7.1: Bovine medical meniscal mold bottom (left) and top (right).
7.2.2 Fiber arrangement stability and scalability
To replicate the anisotripicity of the native meniscus, complex fiber arrangements were 
created and their scalability was explored. To aid in the retention of their shape during 
incorporation into meniscal molds, PVA was used as a tackifying agent. 
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The ability for PVA to serve as a tackifying agent was established though single fiber 
deformation studies. Multiple BFBs of equal length were coated with 10 w% PVA. The 
fibers were held in a U-shape representing 00 with respect to the long BFB axis while 
under atmospheric temperature and pressure. At various time points the fibers were held 
against gravity at one end and the opposite end was allowed to move freely. The resultant 
angle with respect to time was determined. The time required for <10o movement was 
considered a reference point for the time PVA would be needed to coat fibers in a 
complex arrangement prior to incorporating them into the meniscal mold. 
7.2.3 Tri-composite cryogel synthesis
Meniscal molds are modified to permit the incorporation of two liquid phases and one 
solid phase: bulk fiber-reinforced cryogel and superporous cryogel. Glutaraldehyde 
treated FTs will be incorporated into the bulk cryogel making up approximately two-
thirds of the total construct, with the superporous rim making up the remaining one-third. 
FTs will extend from the anterior and posterior horns of the device for use in anchoring to 
the tibial plateau. Care will be taken to prevent the exposure of FTs through the surface
of the cryogel. The mold will be subjected to cryogel synthesis steps previously 
described. 
Qualitative assessment of surface roughness and mechanical integrity will be made 
through handling of the scaffold.  Particular attention will be made in assessing the 
stability of the superporous cryogel-bulk cryogel interface.
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7.3 Results
7.3.1 Fiber stability with a PVA tackifying agent
The ability for PVA to coat a single BFB and lead to shape retention is shown in Figure 
7.2. At ambient temperature and pressure, PVA lead to <10o of BFB deformation by 300
min. 
Figure 7.2: Proof of concept of PVA as a tackifying agent.
7.3.2 Fiber Arrangement Scalability
Previous work has provided a proof of concept that complex fiber arrangements can be 
incorporated into a cryogel and yield a mechanically sound scaffold. Figure 7.3 shows the 
complex arrangement using BFB to recreate the arrangement of collagen fibrils in the 
native meniscus. A protocol was developed to create the construct in a reproducible 
fashion. 
t= 35min
Fiber angle~135
O
t= 100min
Fiber angle~100
O
t= 300min
Fiber angle~0
O
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Figure 7.3:BFB complex anisotropic arrangement (two views).
The arrangement was recreated to scale to match the dimensions of bovine meniscus for 
use in the medial meniscus mold as shown in Figure 7.1. PVA was used as a tackifying 
agent to maintain the three dimensional orientation of the BFB arrangement (Figure 7.4).
The BFB was incorporated into the mold to produce a stable fiber-reinforced cryogel 
without exposed BFB on the cryogel surface as seen in Figure 7.5.
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Figure 7.4: Scaled BFB arrangement.
Figure 7.5: PVA cryogel with UHMWPE fibers matched to the shape of the meniscus
(two views).
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FTs were prepared for PVA tackifying and meniscal shape retention as shown in Figure 
7.6.
Figure 7.6: FT expanded from BFB (A) then set with PVA as a tackifying agent (B) and 
retained shape in meniscal mold (C).
Following injection of PVA into the mold containing glutaraldehyde-treat, PVA-coated
FT, the PVA was allowed to cool for 4 hours producing the fiber-reinforced cryogel. 
Cooling and not complete freezing was done to add the peripheral PVA phase while 
adequate polymer chain mobility remained. A 2 mm thick peripheral rim was excised
from the bulk cryogel and 10 v% ESBOr-20 w% PVA-300 rpm mixed cryogel was 
injected into the mold with the bulk cryogel in place. Food coloring was added to the 
superporous cryogel emulsion to better elucidate the demarcation between superporous 
A B
C
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and bulk cryogel phases. Following freeze-thaw cycling, the tri-composite cryogel was 
removed from the mold as shown in Figure 7.7.  The synthesis steps employed produced
a stable and mechanically sound tri-composite cryogel with smooth surface topography 
indicated no FT extrusion onto the surface. 
Figure 7.7: Tri-composite cryogel with superporous rim (two views).
7.4 Discussion
Based on the results from Aims 1, 2, and 3 optimized cryogel formulations were 
determined for tri-composite cryogel synthesis. PVA was successfully used as a 
tackifying agent for FT although difficulty experienced in recreating the full SF 
separation seen with uncoated FT. Machine processing equipment specialized in handling 
of small diameter coated fibers would be advantageous for future processing of FT for 
incorporation into the PVA bulk phase. The addition of a superporous periphery was 
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successful, with a clear demarcation between superporous and bulk phases seen. The 
benefit of the use of FT as opposed to fibers with necessary orientation and linearity, is 
that reproducibility of composite properties is easier to obtain. The ability to combine to 
components in a controlled fashion and obtain reproducible composite properties is 
tantamount to a successfully translatable meniscal replacement. 
7.5 Conclusion
This Aim was successful in combining the optimal material synthesis parameters 
determined in Aims 1, 2 and 3. Complex fiber arrangements, including the preferred FT, 
high dispersion arrangement was successfully scaled to meniscal dimensions of an ovine 
animal model. This proof of concept demonstrates to potential of a tri-composite, fiber-
reinforced cryogel with a superporous rim, to be successfully used as a novel meniscal 
replacement. 
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Chapter 8: Conclusions and Recommendations for Future Work
The work completed in Aim 1 successfully explored the ability for UHMWPE fibers to 
make a PVA cryogel anisotropic with respect to tensile and compressive forces. The 
successful development of a coupon system created composite specimens in a controlled 
and reproducible fashion. Inter-fiber spacing and fiber volume was shown the affect both 
tensile and compressive modulus. The role of glutaraldehyde surface treatment and 
increases fiber dispersion on IFSS was established. Furthermore, the benefit of highly 
dispersed fibers to resist tear propagation was demonstrated. Aim 1 concludes with the 
selection of optimal synthesis parameters for use in Aim 4. 
The research conducted in this Aim 2 has explored to use of various solvents in the 
liquid-liquid phase separation synthesis of superporous cryogels. The synthesis-structure-
function relationship has been established for this material. High PVA concentration, 
over 20 w%, appears to be needed to obtain modulus values on par with the compressive 
moduli of human meniscus. 
Aim 3 demonstrated that protein can be transported through a superporous and non-
superporous cryogel. The rate of transport is influenced primarily by cryogel water 
content. It was established that an osmotically conditioned cryogel synthesized with 20 
w% PVA maintains its transport properties to that of a non-osmotically conditioning 
cryogel.
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In Aim 4, the work completed has demonstrated the feasibility of incorporating fibers 
into cryogels matching the dimensions of the meniscus. Completion of Aims 1, 2 and 3 
provided the needed information to synthesize each of the tri-composite components to 
produce a biomaterial that is suitable as a meniscal replacement device. 
Future work should focus on further exploring the mechanical performance of highly 
dispersed, fiber-reinforced, glutaraldehyde-functionalized cryogels with higher fiber 
volume fractions using a redesigned coupon system and tested in dynamic loading 
conditions using a knee-simulator. It is also recommended that tests be conducted using 
type I collagen to functionalize the superporous cryogel phase and assess in vitro and in 
vivo cellular migration and proliferation.
The proposed cryogel synthesis method and selected materials employ an innovative
approach that is aimed to be clinically translatable and allow for controllable material 
properties. The development of a fiber-reinforced, anisotropic superporous cryogel will 
provide a positive impact by bringing the field of tissue engineering closer to providing a 
viable treatment option for individuals suffering from debilitating meniscal tears.
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